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The main site for protein degradation along the endosomal pathway is believed to be the late
endosome. Lysosomes are thought to be storage organelles that, when necessary, inject
proteases into the late endosome. It was hypothesised that differences in the lumenal redox
environments between the two organelles could be responsible for their functional
differences. In an attempt to quantify this potential difference, the lysosomal cysteine
protease cathepsin B was isolated by an improved purification procedure. Several
intracellular reducing agents were used to activate cathepsin B, the most effective being
cysteine. Cysteine was used to activate cathepsin B under various pH conditions in order to
model endosomal conditions. An inverse relationship was found between the pH and the
concentration of cysteine required to activate cathepsin B. This suggested that cathepsin B
may have an optimal redox potential. In order to determine this potential, cysteinexystine
redox buffers were made up and used in determination of the activity of the enzyme against a
synthetic and a whole protein substrate (haemoglobin). No distinct redox potential could be
determined using either substrate, but it was found that cystine stimulated proteolysis of
haemoglobin. A similar stimulatory effect was observed for cathepsin D and papain
hydrolysis of haemoglobin. This effect is possibly due to the ability of cystine to promote
substrate structure, effectively increasing the substrate concentration. These findings and
other results obtained from the literature have been used to create a model of how proteolysis
may be regulated along the endosomal system.
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The endosomal system allows a cell to contact and sample the extracellular environment.
Depending on the cell type, nutrients, hormones and potential antigens can be proteolytically
processed within this system. The system is also responsible for the proteolytic destruction
of organelles without threatening destruction of the cell. There are two models to explain the
organisation of the endosomal pathway, the maturation model and the pre-existing
compartment model.
The maturation model predicts that each organelle along the endocytic pathway is a transient,
but distinct, compartment that matures into the next organelle along the pathway. In this
model, the early endosome is formed de novo, by the fusion of many primary endosomes
which are derived from the plasma membrane. This transient compartment then matures into
a transient late endosome, which in turn matures into a lysosome. Each maturation stage has
its own unique set of biochemical markers associated with it. These markers and membrane
components are recycled by earner vesicles during maturation (Griffiths, 1996). In a related
model, proposed by Thilo et al. (1995), maturation occurs from the primary endosome until a
pre-lysosomal compartment is formed. This compartment then communicates with the
lysosome through vesicular traffic.
In the pre-existing compartment model, the early and late endosomes are considered to be
stable, highly specialised compartments linked by vesicular traffic (Griffiths, 1996).
Vesicles, unlike compartments, are incapable of homotypic fusion and have the ability to
mature, i.e. to undergo a complex series of biochemical and physical changes with time. A
further difference between these organelles is in their structure and function. Compartments
tend to be far more structurally complex and have more specialised functions compared to
vesicles (Griffiths, 1996). Whilst the two theories differ on the temporal organisation of the
pathway, the spatial and functional aspects of the pathway are very similar (Fig. 1). The






Figure 1. A comparison of the maturation and pre-existing compartment models
for the organisation of the endosomal pathway.
(a) Maturation model: In this model primary endosomes fuse forming an
early endosome (EE). The early endosome matures into a late endosome
(LE), which in turn matures into a lysosome (LYS). Maturation events are
indicated by a dark arrow, (b) Pre-existing compartment model: In this
model, primary endosomes contact the early endosome (EE) by vesicular
traffic. Carrier vesicles from the early endosome carry material to the late
endosome (LE), which is linked to the lysosome (LYS) by vesicular traffic.
An extracellular particle may enter the endosomal system through receptor-mediated
endocytosis, or through fluid phase endocytosis. The proportion of material taken up
through either of these pathways depends on the cell type. Receptor mediated endocytosis is
a complex process that occurs with clathrin coated vesicles (CCV's). Upon binding to its
cognate ligand, plasma membrane receptors bind specific docking proteins, which in turn
recruit adaptor protein 2 (AP-2) complexes. The AP-2 complexes bind to the cytoplasmic
tails of the receptors using these docking proteins. The entire assembly of the AP-2
complexes on the plasma membrane is controlled by as yet unidentified GTPases, and
possibly kinases and phosphatases (Schmid, 1997).
The AP-2 complexes act as substrates for the binding of cytoplasmic clathrin triskelions.
Initially the clathrin assembles in a planar array, but as the clathrin coated pit curves inward
during maturation, the clathrin assembly becomes more hexagonal. This rearrangement of
the clathrin assembly causes localised distortions in the plasma membrane that are necessary
for vesicle formation. Two further steps are needed to drive the formation of the CCV. In
the first step, the vesicle develops into a clathrin covered pit attached to the plasma membrane
by a narrow neck. The final step requires both ATP and GTP hydrolysis. Whilst the
ATPases have not been identified, a 100 kDa GTPase, dynamin, plays a direct role in CCV
formation. About 20 dynamin molecules, in their active GTP-bound conformations, self-
assemble into a spiral at the neck of the constricted pit. Co-ordinated GTP hydrolysis
tightens the spiral at the neck of the pit resulting in vesicle detachment. Recycling of the
clathrin is undertaken by hsc 70, a constitutively expressed heat shock protein. Factors
required for AP-2 release from the vesicle membrane have not been identified (Schmid,
1997).
Once the CCV loses its coat, it becomes known as a primary endosome. The cargo carried
by a primary endosome can follow one of four different pathways: i) the ligand may
dissociate from the receptor and follow the pathway to the lysosome, ii) the entire receptor-
ligand complex may be directed down the endocytic pathway for destruction, iii) the receptor-
ligand complex may be transported to the opposite side of the cell, and iv) the receptor-ligand
complex may be recycled back to the plasma membrane (Berg et al, 1995). These membrane
fusion events are highly regulated to ensure that vesicles fuse with their target membranes.
The selectivity, frequency and the actual fusion events are directed by Rab proteins
(Schimmoller^a/., 1998).
Rab proteins belong to the Ras superfamily of small GTPases. Rabs are highly conserved
and ubiquitously distributed throughout eukaryotic cells. Over 30 Rab isoforms have been
described, and these proteins confer specificity to the different intracellular transport routes
within the cell. Unique structural elements on the individual Rab proteins allow them to
recognise and be localised to their target membranes. Most Rabs are geranylgeranylated
allowing them to be membrane associated. However, the Rab proteins will only associate
with their target membranes in their active GTP-bound conformations. GTP hydrolysis leads
to inactivation of the Rab protein and subsequent loss of membrane association. The Rab
cycle is regulated and effected by several proteins such as GDP dissociation inhibitor (GDI),
GTPase activating protein (GAP), mammalian suppressor of sec 4 (Mss4) and GDI
displacement factor (GDF) (Valentijn and Jamieson, 1998). A further aspect of the Rab
GTPase cycle is that each Rab protein hydrolyses GTP at a rate that corresponds to the rate of
membrane fusion events directed by that protein (Rybin et al, 1996).
The specificity of membrane fusion events is not directly conferred by Rab proteins, but by
the interaction of soluble N-ethylmaleimide sensitive factor receptor (SNARE) complexes.
SNARE complexes are formed by the interaction of a vesicle- or v-SNARE, with its cognate
t-SNARE found on the target membrane. Genetic experiments have linked Rab function to
SNARE interactions, and this link has been described in a recent model by Schimmoller et
al., (1998). In this model (Fig. 2) the t-SNARE is protected by a t-SNARE protector that
prevents t-SNARE accessibility. Rab proteins in their active GTP-bound conformations
could recruit step-specific docking factors to catalyse the deprotection of t-SNARES,
allowing for v-SNARE-t-SNARE pairing. Because only active Rab molecules can recruit







Figure 2. Model for Rab-mediated vesicle docking.
Transport vesicles carry Rabs in their active, GTP bound conformation.
These Rabs recruit specific docking factors(s) from the cytosol. The
docking-factor Rab complex can recognise a protected t-SNARE, and
catalyse the removal of the t-SNARE protector (TSP). This would allow
for v- and t- SNARE pairing. Not shown in the figure is the release of the
inactive Rab-GDP and docking factor(s) following v-SNARE-t-SNARE
pairing (Schimmoller et al., 1998).
Rab proteins undergo a futile cycle of GTP hydrolysis. This GTPase cycle occurs
independently of membrane fusion. It is believed that the GTPase cycle of the Rab proteins
act as molecular timers for membrane fusion events. For example, Rab 5, which directs one
of the fastest intracellular transport routes, has one of the highest GTPase rates for members
of the Rab family (Rybin et al., 1996). Homotypic fusion between two organelles may be
modulated by this cycle, rather than v-SNARE-t-SNARE interaction (Schimmoller et al.,
1998).
The Rab 5-positive early endosome forms the first stage where contents from the primary
endosomes are mixed. It is also the stage of the endocytic pathway where proteolytic
processing of endocytosed material begins. The proteases responsible for the processing are
delivered from the trans-Golgi network (TGN) to the early endosome by mannose-6-
phosphate receptors (MPR's) (Ludwig etai, 1991). Newly synthesised lysosomal enzymes
have phosphorylated mannose residues that allow them, at neutral pH, to bind to MPR's in
the Golgi. Two types of MPR have been described, the 275 kDa cation independent MPR
(CI-MPR) and the 45 kDa cation dependent MPR (CD-MPR) (Berg et al, 1995). Both
receptors are transmembrane proteins, and upon binding to a lysosomal enzyme, trigger the
recruitment of adapter protein-1 (AP-1) complexes to their cytoplasmic tails. The AP-1
complexes have a low affinity for the MPR cytoplasmic tails and their recruitment is probably
mediated through factors such as ADP-ribosylation factor (ARF)-1. In a process analogous
to CCV formation at the plasma membrane, clathrin triskelions bind to the AP-1 complexes
and are involved in the formation of a coated vesicle (Schmid, 1997). The coated vesicle
buds off from the TGN, loses its clathrin coat and fuses with the early endosome (Ludwig et
al, 1991). Targeting of the vesicle to a prelysosomal compartment is undertaken by the v-
SNARE, syntaxin-6 (Bock etal, 1997).
Lysosomal enzymes that do not bind the MPR's in the TGN may be secreted by default.
These enzymes may be recaptured by membrane bound MPR's (Fig. 3). The cytoplasmic
tails of the MPR's contain internalisation signals that allow the enzyme-receptor complex to
enter the cell by receptor-mediated endocytosis (Johnson and Komfield, 1992). In regulated
secretory cells, which have large granule populations, lysosomal enzyme-MPR complexes
may be inadvertently sorted into these exocytic granule populations at the TGN. The
maturation of the granules is accompanied by progressive acidification, from the neutral
immature granules (IG) to the acidic mature granules (Arvan et al, 1984). Acidification of
the granule could trigger both the dissociation of the lysosomal enzyme from the MPR, and
the inappropriate activation of the enzyme. Thus, MPR's have to be sorted out of the
exocytic pathway at the neutral IG stage. This sorting is accomplished by AP-1 complexes
which can bind to MPR's on the IG's and promote the formation of CCV's. These vesicles
are then targeted to the endosomal system by syntaxin 6 (Klumperman et al, 1998).
There is accumulating evidence that MPR-independent systems for targeting lysosomal
enzymes may also operate in cells. MPR-independent systems have been described for
cathepsin B and cathepsin D in rat hepatic cells (Authier et al, 1995), procathepsin L in
mouse fibroblasts (Mclntyre and Erickson, 1993), and also for procathepsin C in Morris
hepatoma 7777 cells which lack the MPR system (Burge etal, 1991). Enzymes may also be
delivered to different stages along the endocytic pathway by continuous reticular tubules
(Hopkins etal, 1990).
Once the MPR-hydrolase complexes reach the endosomal system, the acidic conditions
within the system trigger the release of the enzyme. The MPR's are recycled back to the
TGN in a Rab 9 dependent manner (Riederer et al, 1994). The factors required for enzyme
dissociation by MPR-independent systems are not known. Proteolytic processing of a
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substrate begins in the early endosome with the bulk of substrate hydrolysis being carried out









Figure 3. Entry pathways for lysosomal hydrolases into the endosomal system.
Lysosomal hydrolases can enter the endosomal system by one of four
pathways, (a) Lysosomal hydrolases can bind to MPR's and leave the
TGN by CCV's. These vesicles fuse with a prelysosomal compartment, and
the MPR's discharge their cargo under acidic conditions, (b) Lysosomal
hydrolases can also enter the endosomal system by as yet uncharacterised
transporters. (c) Lysosomal hydrolase-MPR complexes that are
inadvertently sorted into secretory granules, can be extracted by CCV
formation, (d) Hydrolases that are exported out of the cell can be
recaptured by plasma membrane MPR's and routed to the endosomal
system by receptor-mediated endocytosis. The presence of clathrin is
indicated by dark lines.
The next stage along the endosomal system is the endosomal carrier vesicle (ECV).
According to the pre-existing compartment model, ECV's bud off from the early endosome
and carry material destined for degradation to the late endosome. ECV's are between 0.3-
0.4 uM spherical vesicles that have a distinctive membrane enriched lumenal content. The
lumenal pH of the ECV drops from the early endosomal pH of 6.0-6.5 to values of pH 5.0-
5.5 as the vesicle matures. The ECV movement between the early and late endosomes is
microiubule dependent. The ECV's lack the ability to fuse with one another or with the early
1
endosomes that they were derived from, but are capable of fusing with late endosomes
(Griffiths, 1996).
The ECV fuses with the next stage of the endosomal pathway, the late endosome. The late
endosome is morphologically and functionally distinct from the lysosome. The late
endosome has a relatively complex organisation and a lighter density on Percoll or sucrose
gradients when compared to lysosomes. Lysosomes tend to be smaller, more spherical,
organelles of high density. A further difference is that late endosomes have markers like
Rab 7, the 2 MPR's and the regulatory (RII) domain of the CAMP-dependent protein kinase,
that are not present on lysosomes. Both organelles have about equal concentrations of
lysosomal associated membrane proteins (LAMP's), whose function is not yet known
(Griffiths, 1996).
Despite these morphological differences, in much of the literature there is a failure to
appreciate the distinction, and the functional differences, between these two organelles and
the term "lysosomes" is often used loosely. The original definition of lysosomes was that
they were acidic organelles, containing acid hydrolases. From a modern perspective, this
definition encompasses both lysosomes and late endosomes, though lysosomes may not all
be acidic (Butor et al., 1995). A modem definition of lysosomes is that they are terminal
vesicles on the endosomal pathway that are relatively dense, and which are devoid of
recycling receptors, such as the two MPR's (Griffiths, 1996).
The position of lysosomes on the endosomal pathway, and the absence of receptors are
properties most easily determined by microscopical studies, including immunocytochemistry.
Density is frequently used in sub-cellular fractionau'on by centrifugation to isolate lysosomes.
Often however, inadequate consideration is given to the contamination of genuine lysosomal
fractions by late endosomal fractions (Griffiths, 1996). Great care is therefore necessary
when interpreting exactly what any particular author means when using the term lysosome.
In those density gradient fractionation experiments where the author(s) have not made the
distinction between late endosomes and lysosomes, the term lysosome is placed in inverted
commas to indicate this. The hydrolases within the endosomal system, despite not being
confined to the lysosome, have retained the prefix "lysosomal", for convenience.
Most (80-90%) of the total lysosomal hydrolase pool resides in the lysosome, with the
exception of human fibroblasts where there is an equal division of the enzyme pool between
the two organelles (Rome and Crain, 1981). Using an 125I -labelled-tyramine cellobiose-
ovalbumin conjugate, whose degradation products remain trapped at their site of formation, it
was demonstrated that despite only having 20% of the total lysosomal hydrolase pool, the
bulk of proteolysis (80%) appears to occur in the late endosome. It was reasoned that
lysosomes may be storage organelles that when necessary inject part of their hydrolase pool
into the late endosome, where the bulk of substrate hydrolysis occurs (Tjelle et al, 1996).
These results suggest that there must be a regulatory mechanism that injects hydrolases into
the late endosome when necessary. Secondly, they suggest that the environment within the
late endosome must support proteolysis when compared to the lysosomal environment.
Clues to the regulatory mechanism that injects proteases into the late endosome may have
been described in J774 macrophages in a recent paper by Claus et al. (1998). These authors
found that subsets of lysosomal proteases were injected into phagosomes, and could be
sorted out of them depending on phagosomal pH. The details of such an envisaged
regulatory mechanism must await further investigation.
The second question raised by the work of Tjelle etal. (1996) is how the environment of the
late endosome supports proteolysis. Alternatively, how does the lysosome ensure that
proteolysis is 'switched off. This activation mechanism that distinguishes these two
organelles must fulfil 4 requirements:
• It must be able to account for the activation of proteolysis within the late endosome when
compared to the lysosome.
• The activation mechanism must be able to operate over a wide range of pH values. Butor
et al., (1995) have demonstrated that late endosomes/lysosomes have pH values that
fluctuate between pH values less than 4, up to alkaline pH's. These pH conditions are
presumably necessary to accommodate the widely different pH optima of the various
lysosomal hydrolases.
• The activation mechanism must apply to all the lysosomal hydrolases within the system.
• Ideally, the system should account for the morphological differences between late
endosomes and lysosomes.
In the present study, attention was focused on the lysosomal proteases. Lysosomal
endoproteases are mainly cysteine proteases, which are functional only under reducing
conditions. The crystal structure of the lysosomal cysteine protease cathepsin B showed that
the active site thiol residue was in the form a reversible sulfinic acid (Musil et al., 1991).
Reducing conditions convert the sulfinic acid into a thiol, and depending on the pH, activate
the protease. It was consequently hypothesised that the functional/activational differences
between the late endosomes and lysosomes could reflect differences in their intralumenal
redox potential, i.e. late endosomes might support proteolysis by maintaining a relatively
reducing environment. Conversely, the relatively oxidising conditions within the lysosome
might inactivate the cysteine proteases, storing them in a latent form. Thus, proteolysis could
be regulated without the need for inhibitors and regulatory systems for these inhibitors.
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Besides activating cysteine proteinases, reducing conditions also promote proteolysis by
breaking the disulfide bonds of a substrate protein, thus relaxing the substrate structure. This
in turn exposes more potential sites for proteolysis. Using the lysosomal enzymes cathepsins
B, D, H and L, it was found that reducing conditions and proteolysis act synergistically to
degrade a substrate (Kooistra et al, 1982). Disulfide reduction appears to be a pre-requisite
for the proteolytic processing of certain antigens. Using the substrates bovine ribonuclease A
(RNAse) and hen egg lysosome, it was found that prior reduction and carboxymethylation of
these substrates resulted in increased antigen presentation by peritoneal macrophages when
compared to the response elicited by native substrates (Collins et al, 1991). In contrast to
the results of Kooistra et al. (1982), these authors also found that disulfide cleavage of their
redox probe, a-2 macroglobulin-bisthiopropionyl-glycyl tyrosine, occurred independently of,
and before significant proteolytic degradation (Collins et al, 1991).
The reducing conditions within the "lysosome" are generated by a cysteine-specific
transporter. Clues to the existence of the transporter came from uptake studies of ^5S-cystine
in human fibroblasts. It was found that 50-60% of the total radioactivity was associated with
the "lysosomal" compartment in the form of cysteine. Further, this uptake was rapid,
occurring within 2-5 min of the pulse (Elferink et al, 1983). Pisoni et al. (1990) described
the properties of the transporter in human fibroblasts. The transporter displays a Km of
53 uM for cysteine uptake at pH 7.0 and 37°C. It also exhibits the highest activation energy
for any known lysosomal transport system. The transporter is highly specific for cysteine,
and displays an optimal pH between 7.2-8.0.
The reduction of a disulfide bridge within a substrate generates the oxidised form of cysteine,
cystine (Segal, 1976). A transport system for cystine efflux has also been described. A
defect in this system is responsible for the disease cystinosis. Efflux of cystine from
"lysosomes" occurs with a half-time of 25-45 min at 37°C and pH 7.0 in human leukocytes,
fibroblasts and lymphoblasts. Cystine efflux is stimulated by MgATP and by the polyamines
spermidine, putrescine, cadaverine and spermine. Interestingly, human leukocyte lysosomes
can take up cystine, with a pH optimum between 5.5-6.5. Km values of 0.3-0.5 uM for
cystine uptake at pH 7.0 and 37°C have been described in human leukocytes and mouse
fibroblasts (Pisoni and Thoene, 1991).
Cystine that is transported out of the lysosome is reduced in the cytoplasm. The cytoplasm
has a high concentration of the tripeptide, glutathione (GSH). GSH is the principle
cytoplasmic reducing agent and is responsible for maintaining a reducing environment in the
cytoplasm. GSH reduces cystine to form cysteine and a mixed disulfide of GSH and
cysteine. This latter product is further metabolised to generate GSH and cysteine (Meister,
1995).
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Meinesz (1996) developed a dual fluorescent labelling system in order to determine whether
the endosomal system in the breast cancer cell line MCF-10A, contained lysosomes that were
relatively oxidising. The LysoTracker probe was used to label lysosomes, whilst the dye C-
2938 was used to determine which organelles were oxidising. However, at the outset of this
present study it was found that the C-2938 dye was pH and redox sensitive. Thus, the
changes in fluorescence associated with the dye may not reflect changes in redox potential,
but changes in pH. Because of the inherent uncertainty associated with using the C-2938
dye, attention was focused on the enzymes themselves. The lysosomal cysteine protease,
cathepsin B was chosen for study because a convenient and rapid isolation procedure of this
enzyme had been developed in this laboratory. The ability of cathepsin B to be activated by
various reducing agents was investigated to determine whether the enzyme could be activated
under non-lysosomal conditions. The relationship between pH and reduction potential on
cathepsin B activation was also explored to determine possible activation states of the enzyme
along the endosomal pathway. Finally, an attempt was made to determine the optimal redox




This chapter will describe fundamental methods that were used during the course of this
research project. In addition, specialised or novel procedures that would hinder the structure
of following chapters are described in detail.
2.1 Materials
Most of the common chemicals used during this study were purchased from BDH, Merck or
Boehringer Mannheim and were of the highest purity available. Coomassie brilliant blue
R-250 was from Merck. Acrylamide; N,N'-methylbisacrylamide; N,N,N',N'-
tetramethylethylenediamine (TEMED), dioxane and dimethylformamide were from BDH.
Dialysis tubing, 7-amino-4-methyl coumarin, dithiothreitol (DTT), L-trans-epoxysuccinyl-
leucylamido(4-guanidino) butane (E-64) and Sephacryl S-100 were from Sigma, St. Louis,
MO. The materials for constructing the pepstatin affinity resin, pepstatin A,
aminohexylagarose, N-hydroxsuccinimide and dicyclocarbodiimide, as well as the protease
substrates CBz-R-R-AMC, CBz-F-R-AMC, haemoglobin and azocasein, were also from
Sigma. The cation exchange chromatography gel, S-Sepharose, was from Pharmacia
Biotech, Uppulsa, Sweden. The P-60 molecular exclusion gel and the hydroxyapatite
medium were from Bio-Rad Laboratories, Richmond, CA. UltraFuge ultrafiltration
centrifuge filters were from Micron Separations Inc., Westbro, MA.
2.2 Protein assays
The Bradford dye-binding assay (Bradford, 1976), as modified by Read and Northcote
(1981), was used for protein quantification.
2.2.1 Bradford dye-binding assay
The Bradford dye-binding assay is based on the binding of the dye, Coomassie brilliant blue
G-250, to protein. The assay allows for rapid, accurate, and reproducible protein
quantification. In addition, the assay requires small amounts of sample, and is resistant to
interference by chemicals commonly used during protein purification like Tris, ethylene
diamine tetra-acetic acid (EDTA), Triton X-100 and sodium dodecyl sulfate (SDS).
The Coomassie brilliant blue G-250 dye exists in three forms, an anionic blue form, a neutral
green form and a cationic red form. The cationic form has an absorption maximum at
470 nm. Upon binding to protein the cationic form is converted to the blue species which
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has an absorption maximum at 595 nm. This shift in absorbance maximum allows for
spectrophotometric quantification of protein. The extinction coefficient at 595 nm of the dye-
protein complex is much greater than that of the unbound dye and is responsible for the high
sensitivity of the assay.
A large proportion of the dye binding energy is due to non-ionic interactions. This results in
variation in the binding properties of the dye with different proteins. In order to minimise
this variation, Read and Northcote (1981) modified the acid/alcohol ratios and increased the
dye concentration used in the dye reagent. The micro-assay of Read and Northcote (1981)
was used in this study for the determination of 1-5 ug of protein.
2.2.1.1 Reagents
Dye reagent. Serva blue G dye (50 mg) was dissolved in 88% phosphoric acid (50 ml) and
99.5% ethanol (23.5 ml). This solution was made up to 500 ml with dist.H2O and stirred for
30 min. The resulting solution was filtered through Whatman No. 1 filter paper and stored in
an amber coloured bottle. Visual checks for precipitation were made prior to use and if
precipitation was observed, a new batch of reagent was made up.
Standard protein solution. A 0.1 mg/ml ovalbumin solution was made up in dist.H2O.
2.2.1.2 Procedure
Samples were diluted to 50 ul with dist.H2O, dye reagent (950 ul) was added, and the
solution was mixed and allowed to stand for 2 min for colour development. The absorbance
was read at 595 nm against appropriate blanks. Plastic microcuvettes (1 ml) were used, as
the dye reagent binds to glass (Bradford, 1976). The blue stained plastic microcuvettes
could easily be cleaned with diluted sodium hypochlorite. A standard curve, relating
absorbance at 595 nm to 0-50 ul (0-5 ug) of the standard protein was constructed by linear
regression analysis of the standard curve data.
2.3 Concentration of enzyme samples
Many of the enzyme isolation procedures used during this study required concentration of the
dilute protein samples before they could be used. An inexpensive and simple method of
concentrating samples was by dialysis against sucrose or polyethylene glycol (PEG).
Samples were placed in dialysis tubing with a cut-off of 12 kDa and dialysed against either
sucrose or PEG. Osmotic pressure results in the continuos efflux of water and buffer ions
from the dialysis bag, concentrating the sample. PEG (20 kDa) tends to interfere with protein
quantification and enzyme activity assays but, unlike sucrose, does not enter the dialysis bag.
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When necessary, these two concentration methods were supplemented using concentration
with UltraFuge Ultrafiltration Centrifuge Filters. The UltraFuge filters are divided into two
chambers separated by a filter with a M,. cut-off of 10 000. Dilute samples were loaded into
the upper chamber and the UltraFuge filters were centrifuged (2 000 x g, 30 min, 4°C).
Under these centrifugal forces, water and buffer ions pass through the membrane, while the
target proteins, which were usually between 30-50 kDa, are retained. This method of
concentration has none of the disadvantages associated with sucrose or PEG. These filters
did prove to be problematic, however, often rupturing at very low centrifugal forces.
2.4 Electrophoretic techniques
2.4.1 Tris-Tricine SDS-PAGE
The Tris-tricine sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
system was designed to resolve smaller proteins (< 100 kDa) which are sometimes poorly
resolved by conventional Laemmli SDS-PAGE. In this system, tricine rather than glycine is
used as the trailing ion in the stacking phase. Tricine, and the higher pH of the stacking
phase, causes an increase in the mobility of the protein relative to the trailing ion, allowing for
the separation of low molecular weight protein-SDS complexes (Schagger and von Jagow,
1987).
2.4.1.1 Reagents
Monomer solution [49.5% (m/v) acrylamide (T), 3% (m/v) N.N'-methylene-bisacrylamide
(C)]. Acrylamide (48.0 g) and N,N'-methylene-bisacrylamide (3.0 g) were dissolved in
dist.H2O and made up to 100 ml. This solution was filtered through Whatman No. 5 paper
and stored at 4°C in the dark.
Gel buffer \3 M Tris-HCl. 0.3% (m/v) SDS. pH 8.451. Tns (72.7 g) was dissolved in
200 ml dist.H2O, and adjusted to pH 8.45 with HC1. 10% (m/v) SDS (6 ml) was added and
the solution made up to 250 ml.
10 % (m/v) SDS. SDS (10 g) was dissolved in 100 ml dist.H2O.
Anode buffer F0.2 M Tris-HCl. pH 8.91. Tris (24.22 g) was dissolved in 950 ml of
dist.H2O, adjusted to pH 8.9 with HC1 and made up to 1 litre.
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Cathode Buffer 10.1 MTris-HCl. 0.1 MTricine. 0.1% (m/v) SDS. pH 8.251. Tris (12.1 g),
Tricine (17.9 g) and 10% (m/v) SDS (10 ml) were made up to 1 litre with dist.H2O and the
pH checked.
Treatment buffer 1M25 mM Tris-HCl. 4% (m/v) SDS. 20% (v/v) glvcerol. 10% (v/v) 2-
mercaptoethanol, 0.01% (m/v) Serva blue G, pH 6.81. Stacking gel buffer (2.5 ml), glycerol
(2 ml), 10% (m/v) SDS (4 ml) and 2-raercaptoethanol (1 ml) were made up to 10 ml with
dist.H2O. Serva blue G tracking dye [0.01% (m/v)] was added. For non-reducing SDS-
PAGE, 2-mercaptoethanol was omitted. Samples were boiled in treatment buffer before
electrophoresis.
2.4.1 .2 Procedure
The composition of the resolving and stacking gels used to constnict the Tris-Tricine system
are described in Table 1. The gels were run at 80 V with unlimited mA, and stopped when
the Serva blue dye reached the bottom of the gel. The gels were stained as described in
section 2.5.
Table 1. Preparation of resolving and stacking gels for Tris-Tricine SDS-PAGE.
Reagents



















2.5 Silver staining of electrophoretic gels
Protein bands were visualised using silver staining, which is at least 50-100 times more
sensitive than conventional Coomassie staining and can detect protein in the nanogram range.
The basis of silver staining is the complexation of silver ions to the ionic side-chains of amino
acids. This binding is responsible for the sensitivity of the technique. The silver-amino acid
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complex is visualised by reduction with formaldehyde. Reducing reactions are strongly
favoured under alkaline conditions and these conditions were generated using Na2CO3 The
colour produced upon reduction of the silver-amino acid complex depends on the moiety that
the silver ion binds to and the length of the bond and its configuration (Nielson and Brown,
1984).
Sodium thiosulfate complexes and removes native silver ions present in the gel that may
contribute to background staining. Treatment of gels with sodium thiosulfate decreases the
levels of background staining without impairing sensitivity (Blum et al, 1987).
2.5.1 Reagents
Fixing solution [50% (v/v) methanol. 12% (v/v) acetic acid, 0.2% (v/v) formaldehydel.
Methanol (100 ml), glacial acetic acid (24 ml) and 37% formaldehyde (0.1 ml) were made up
to 200 ml with dist.H2O.
Wash solution 150% (v/v) ethanoll. Absolute ethanol (100 ml) was made up to 200 ml with
dist.H2O.
Pre-treatment solution ID.02% (m/v) Na2S2O:.5H2Ol. Na2S2O3.5H2O (0.1 g) was made up
to 500 ml with dist.H,O.
Impregnation solution r().2% (m/v) AgNCX. 0.03 % (m/v) formaldehvdel. AgNO3 (0.4 g)
and 37% formaldehyde (0.15 ml) were made up to 500 ml with dist.H2O.
Development solution [6% (m/v) Na2CO3. 0.0004% (m/v) Na2S2O3.5H:O. 0.02% (v/v)
formaldehyde"!. Na2CO3, (12 g), pre-treatment solution (4 ml) and 37% formaldehyde
(0.1 ml) were made up to 200 ml with dist.H2O.
Stop solution [50% (v/v) methanol. 12% (v/v) acetic acid]. Methanol (50 ml) and glacial
acetic acid (12 ml) were made up to 100 ml with dist.H.,0.
2.5.2 Procedure
All steps were earned out at room temperature in clean glass containers. All glass containers,
including volumetric flasks, were washed with dist.H2O and Ultrapure Milli-Q water. After
electrophoresis, gels were soaked in fixing solution for either 1 h or overnight. Overnight,
fixing significantly reduced background staining. Following fixation, the gels were treated
with wash solution (3 x 20 min). These washing steps allowed for the treatment of gels with
acid labile Na2S2O3.5H2O, and could be increased to 30 min washes to reduce background
staining. The gels were treated with pre-treatment solution (1 min), rinsed with Ultrapure
Milli-Q water (3 x 20 s) and soaked in impregnation solution (20 min). After rinsing with
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Ultrapure Milli-Q water (3 x 20 s), the gel was immersed in development solution until bands
became visible. The gel was rinsed with Ultrapure Milli-Q water , treated with stop solution,
and stored in a sealed plastic bag at 4°C until needed.
2.6 Protein fractionation using three phase partitioning (TPP)
TPP is an upstream purification method used to selectively concentrate proteins. Tertiary
butanol is usually completely miscible with water, but upon the addition of ammonium sulfate
the solution partitions into two phases; an upper t-butanol phase and a lower aqueous phase.
If proteins are present within the solution, they may, depending on the ammonium sulfate
concentration, precipitate into a third phase between the upper t-butanol and lower aqueous
phases (Pike and Dennison, 1989a).
An advantage of TPP when compared to most conventional ammonium sulfate precipitation
methods is that the precipitate is essentially free of contaminating salt, which remains in the
aqueous phase. The precipitate can therefore be directly applied to an ion-exchange column
without the need for desalting steps. A further advantage of TPP is that lipids and other
hydrophobic compounds are extracted into the t-butanol phase. TPP does tend to denature
oligomeric proteins. This property was exploited in the purification of cathepsin D from
bovine spleen where haemoglobin is a major contaminant (Jacobs et al, 1989).
The mechanism underlying TPP has been described in detail by Dennison and Lovrien
(1997). TPP precipitation of proteins is a result of the co-operative effects of ammonium
sulfate and t-butanol. The sulfate ion effects protein precipitation by six interdependent
mechanisms: ionic strength effects, kosmotrophy, cavity surface tension enhancement,
dehydration, exclusion-crowding, and ionic interactions with cationic groups on the protein.
The latter effect is prevalent at low ammonium sulfate concentrations, when the concentration
of ammonium sulfate is in the range 0.1 to 0.2 M. These ionic interactions could explain the
strong pH dependency of the method. At higher concentrations, 0.4 to 4 M sulfate, ionic
strength effects, kosmotrophy, cavity tension enhancement, dehydration and exclusion-
crowding come into operation. The net effect of these factors is the conformational shrinkage
and contraction of a protein, promoting protein co-crystallisation. Further, this tightening of
protein conformation stabilises protein structure, preventing denaturation.
The remarkable protective properties of ammonium sulfate are reinforced by t-butanol.
t-Butanol behaves as a kosmotrope and a crowding agent, promoting protein structure and
enhancing the salting out effect of ammonium sulfate. t-Butanol is able to fulfil these co-
solvent functions at room temperatures, whereas C\ and C2 co-solvents (like ethanol) require
low temperatures. The flotation of a protein into the third phase (between the t-butanol and
aqueous phases) is due to an increase in the relative butanolation and concomitant dehydration
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of the protein. These effects, mediated by ammonium sulfate, increase the buoyancy of the
protein allowing it float above the salt-containing aqueous layer. Butanolation can however,
cause denaturation of oligomeric proteins by promoting non-native alpha helical
conformations in protein structure (Dennison and Lovrien, 1997).
TPP has been used to purify the lysosomal proteinases cathepsins L (Pike and Dennison,
1989b), D (Jacobs et al, 1989), S (Meinesz, 1996) and B (Meinesz, 1996). In this study
TPP was used to purify bovine liver cathepsins B and D.
2.6.1 Procedure
t-Butanol was mixed into the aqueous solution to be fractionated to a final volume of 30%
(v/v). The volume of t-butanol required was calculated form the equation:
y = (0.3/0.7) x
where y = volume of t-butanol
x = volume of aqueous solution
t-Butanol crystallises below 25°C and was therefore warmed to 30°C prior to use. Solid
(NHZO2SO4 [% (m/v) based on the total volume of the mixture including t-butanol] was
added to the mixture and dissolved by stirring. This mixture was centrifuged (8000 x g,
10 min, 4°C) in a swing-out rotor, leaving a firm button of precipitate between the t-butanol
and aqueous phases. If necessary, further (NH^SC^ was added and the solution
centrifuged as before. This allowed a cut of the protein of interest to be made from the total
protein content of the solution. The precipitate was dissolved in an appropriate buffer,
centrifuged (15 000 x g, 10 min, 4°C), and filtered through Whatman No. 4 filter paper to
remove undissolved protein.
2.7 Hydroxyapatite chromatography
In the purification of cathepsin S, Meinesz (1996) employed hydroxyapatite (HA)
chromatography to separate cathepsin S from two contaminating bands that could not be
removed by conventional ion-exchange or molecular exclusion chromatography. The
resolving power of the technique is based on the differing retention mechanisms for acidic
and basic proteins. These differing mechanisms of binding can allow the hydroxyapatite
column to behave as a cation and an anion exchanger in a single run. The mechanism of
hydroxyapatite chromatography has been described by Gorbunoff (1985).





Carboxylic acids groups are repelled by negative charges on the column. These moieties bind




Like in conventional ion-exchange chromatography, factors like the pi, charge distribution
and the concentration of the protein of interest will determine the affinity with which a basic
or acidic protein binds to a column.
There are two methods available to displace amino groups from the column. Firstly Debye-
Huckle charge screening uses anions like P , Cl~, CIO", SCN" and phosphate to disrupts the
amino phosphate interaction. Alternatively, calcium and magnesium ions which complex the
column phosphates can be used to displace the amino-phosphate interactions:
HAPO4"-—H3
+N-protein + CaCl2 -> HAPO4"— -Ca
2++ 2 Cl" + H3
+N-protein
Carboxylic acid groups are displaced from their hydroxyapatite-calcium sites by ions, Like
fluoride or phosphate, which form stronger complexes with calcium than do carboxyls:
HACa2+—--OOC-protein + NaF (PO,-) -> HACa2+—-F (PO -) + Na+ + -OOC-protein
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The formation constants for the calcium fluoride or calcium phosphate complexes are very
much greater than the calcium carboxyl complexes, and hence the displacement of the
carboxylic acids occurs at relatively low molarities of fluoride or phosphate.
The hydroxyapatite medium is in the form of blade-like crystals. As a result, the column has
a weak binding capacity when compared to conventional bead media. Further, the brittle
blade-like crystals tend to form fines. These drawbacks mean that hydroxyapatite
chromatography is best employed downstream in a purification procedure. The versatility of
the column, however, does tend to outweigh these disadvantages.
2.8 Pepstatin aminohexyl affinity resin
The fungally derived aspartic proteinase inhibitor pepstatin A, Isovaleryl-Val-Val-Sta-Ala-
Sta, binds to cathepsin D with a strong, stable and reversible interaction. This interaction
was exploited to purify cathepsin D by affinity chromatography. The pepstatin aminohexyl




Pepstatin A (21.4 mg) was esterified with N-hydroxsuccinimide (3.6 mg) in the presence of
dicyclohexylcarbodiimide (6.45 mg). The entire activation reaction was effected in
dimethylformamide (1.25 ml) for 22 h (4°C). Aminohexyl agarose (2 g suction dry weight)
was suspended in dioxane (3.5 ml) and added to the activated pepstatin solution. The
coupling reaction was allowed to occur in a desiccator with gentle stirring (24 h, room
temperature). The gel was filtered and washed with a dimethylforrnamide/dioxane mixture
(1:2 v/v, 100 ml), followed by a wash with 1 M NaCl. The gel was poured into a glass




ISOLATION OF THE LYSOSOMAL ENZYMES, CATHEPSIN B
AND CATHEPSIN D
3.1 Introduction
Since de Duve's classical studies on lysosomes (de Duve, 1983; Bainton, 1981), advances in
cell biology have shown that endocytosis and proteolysis along the endocytic pathway are
complex and dynamic processes. As the envisioned pathway has become more complex, the
roles assigned to the hydrolytic enzymes within the system has also undergone revision.
The lysosomal cysteine proteinase, cathepsin B [EC 3.4.22.1], is ubiquitously distributed
throughout mammalian cells and its main role appears to be in protein turnover. Cathepsin B
also plays important roles in bone reaborption and antigen and hormone processing. It has
been implicated in pathological conditions like rheumatoid arthritis, tumour metastasis,
inflammation and, possibly, demyelination of neural tissue (reviewed in Yan et al., 1998;
Mort and Buttle, 1997; Lah and Kos, 1998). Cathepsin D [EC 3.4.23.5] is an aspartic
protease that is also widely distributed throughout mammalian cells. Like cathepsin B, the
main role of cathepsin D within the lysosome is believed to be protein turnover. Cathepsin D
is also believed to be responsible for activating the cysteine proteinases, cathepsin B (Van der
Stappen et al, 1996) and cathepsin L (Nishimura et al., 1989; Wiederanders and Kirschke,
1989). Cathepsin D is also involved in antigen (Rodriguez and Diment, 1992) and hormone
processing (Pillai et al, 1983), and in pathological conditions like tumour metastasis
(Capony et al, 1989; Brouillet et al, 1990).
In order to undertake the studies described in Chapter 4, purification schemes that were rapid
and cheap had to be developed for isolating these enzymes. The purification schemes used in
this study were based on previous studies in this laboratory on the isolation of cathepsin B
(Meinesz, 1996) and cathepsin D (Jacobs etal, 1989) from bovine spleen. In this study the
enzyme was isolated from bovine liver, and the differences in the purification protocols
reflect the differences in protein composition between the two tissues.
21
3.2 Cathepsin B
Regulation of the cathepsin B gene is not well understood. Human cathepsin B pre-mRNA is
transcribed from a single copy gene mapping to chromosome 8p22 (Wang et al, 1988). The
5' flanking region of the gene has multiple transcriptional start sites, suggesting more than
one promoter (Berquin et al, 1995). The main promoter region is localised 200 bp upstream
of exon one (Yan et al, 1998). Whilst this region has features of a housekeeping gene,
expression of the cathepsin B mRNA is highly variable between different tissues in the rat
(San Segundo et al, 1986) and mouse (Qian et al, 1989). This suggests that expression of
the gene may be controlled in a tissue or cell specific manner, and that cathepsin B may
participate in tissue specific functions other than intra-endosomal protein degradation (San
Segundo et al, 1986).
Alternate splicing of the cathepsin B pre-mRNA transcript can result in considerable variation
and heterogeneity of the transcripts produced. Most variation between the transcripts is
localised in the 5' and 3' untranslated regions. Differences in these untranslated regions may
result in different steady state mRNA levels, as well as differing rates of translation (Berquin
et al, 1995). Thus regulation of the cathepsin B gene appears to occur at the transcriptional
and post-transcriptional level, and may result in considerable differences in the types of
transcripts and the level at which they are produced.
The cathepsin B mRNA docks onto the ribosomes of the endoplasmic reticulum (ER) and is
transcribed into a pre-propeptide. The signal sequence of the pre-propeptide is cleaved co-
translationally and the propeptide folds into its correct conformation within the ER lumen.
Cathepsin B is roughly disk shaped with a diameter of 50 A and a thickness of 30 A. The
enzyme is bi-lobular with a left (L) and right (R) domain separated by a water-filled interface.
The L and R domains interact by polar contacts along this interface. In addition, polypeptide
straps starting at the N and C termini, respectively, span the interdomainal interface holding
the two lobes together (Musil et al, 1991). Bovine cathepsin B has a further interdomainal
strap: a Cys-148-»Cys-252 disulfide bridge (amino acid numbering for mature enzyme)
(Baudys et al, 1990).
The interdomainal interface opens to form a V-shaped active site cleft. The active site is
buttressed by a unique structural feature, a conformationally flexible 22-residue loop, known
as the occluding loop. The propeptide chain runs along the interdomainal interface from the
enzyme's N-terminus to the active site. The propeptide is held in place by hydrophobic and
hydrophilic contacts along the interdomainal interface. The occluding loop, which normally
blocks the rear of the active site, is displaced away from the enzyme surface by the propeptide
chain (Turk etai, 1996).
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The pro-region of the enzyme prevents the improper activation of the enzyme whilst it is
travelling through the biosynthetic and sorting machinery of the cell. In addition, the pro-
region increases the stability of the enzyme at alkaline and neutral pH, preventing
denaturation (Mort and Buttle, 1997). The enzyme is transferred from the ER to the cis face
of the Golgi where it is glycosylated with an Asn-linked oligosaccharide. This carbohydrate
is phosphorylated by the transfer of a N-acetylglucosaminylphosphate group to the C-6
hydroxyl groups of one or two mannose residues (Hasilik, 1992).
Phosphorylation of the oligosaccharide serves two purposes. Firstly, it prevents the
formation of complex oligosaccharides on the enzyme's surface. Secondly it allows the
proenzyme to bind to the mannose-6-phosphate receptors (MPR's). These receptors deliver
the pro-enzyme to the endosomal system, where the acidic conditions trigger the dissociation
of the enzymes from their MPR's (Hasilik, 1992). Pro-cathepsin B may also reach the
endosomal system by MPR-independent systems (Authier et al., 1995; Mclntyre et al, 1993;
Burge etal, 1991; Hopkins eta!,, 1990).
Once the enzyme reaches the endosomal system, it is activated either by autocatalytically or
by other proteases. The propeptide region is cleaved off and degraded. Cathepsin B
undergoes a further proteolytic cleavage, removing the dipeptide Ala-48/His-49, which
converts the enzyme from a single polypeptide chain into a two chain form. This is the
predominant form of the enzyme within the endosomal system (Musil et al., 1991).
3.2.1 Fluorometric assay for cathepsin B and cathepsin L activities
The fluorometric substrate CBz-R-R-AMC has proved to be an ideal substrate for
cathepsin B. The AMC leaving group is non-toxic, and is sensitive enough for the detection
of picomolar amounts of enzyme. Cathepsin B favours an arginine at the PI position, where
it can be electrostatically anchored to a glutamic acid in the SI position (Musil et al., 1991).
While cathepsin B can cleave the substrates CBz-R-AMC and CBz-F-R-AMC, these can be
also cleaved by cathepsins H and L, respectively. Both cathepsin H and cathepsin L, and in
fact most of the other mammalian cysteine proteases, cannot hydrolyse the CBz-R-R-AMC
substrate, making it a relatively specific substrate for cathepsin B (Barrett and Kirschke,
1981). Two assays were used in this study, a microassay for monitoring the enzyme
purification, and a macroassay for more sensitive readings.
3.2.1.1 Reagents
Buffer/activator rO.l M Na-phosphate. 4 mM Na.EDTA. 0.02% NaN3. 5 mM dithiothreitol,
pH 6.01. NaH2PO4 (6.90 g), Na2EDTA (0.93 g) and NaN, (0.1 g) were dissolved in 450 ml
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dist.H,O, adjusted to pH 6.0 with NaOH and made up to 500 ml. Immediately before use,
dithiothreitol was added to 5 mM (i.e. 0.51 g/500 ml).
1 mM CBz-R-R-AMC substrate stock solution. CBz-R-R-AMC (3.1 mg) was dissolved in
dimethyl sulfoxide (DMSO) (5 ml), divided into 100 ul aliquots and stored at -4°C. When
required, this stock was diluted in dist.H2O to a working concentration of 40 uM .
1 mM CBz-F-R-AMC substrate stock solution. CBz-F-R-AMC (1 mg) was dissolved in
DMSO (1.5 ml), divided into 100 ul aliquots. When required, this stock was diluted in
dist.H,0 to give a working concentration of 20 uM.
Diluent [0.1% Briji. Brij (0.1 g) was dissolved in 95 ml of distilled water and made up to
100 ml.
1 mM 7-amino-4-methylcoumarin standard solution. 7-amino-4-methylcoumarin (1.8 mg)
was dissolved in DMSO (10 ml) and stored in a light-proof bottle at -20°C. Appropriate
dilutions of the stock solution were made in dist.H.,0.
3.2.1.2 Procedure
Microassay. Buffer/activator (75 ul) was added to the enzyme sample (10 ul) in a white
Fluronunc maxisorp microtitre plate. This mixture was incubated at 37°C for 2 min and
substrate solution (25 ul) was added in. After 10 min at 37°C, the fluorescence of the
liberated 7-amino-4-methylcoumarin was measured in a fluorescence microplate reader
(Cambridge Technology, Model 7620) with excitation at 370 nm and emission at 460 nm.
Enzyme activity was described as arbitrary fluorescence units.
Macroassay. The enzyme sample was diluted to 125 ul and buffer/activator (750 ul) added
in. The mixture was incubated for 2 min at 37°C to activate the enzyme and subsu-ate solution
(125 ul) was added in. The fluorescence of liberated 7-amino-4-methylcoumarin was
measured continuously for 10 min in a Hitachi F-2000 spectrofluorometer with excitation at
370 nm and emission at 460 nm. Enzyme activity was described by the SI unit for enzyme
activity, the katal.
Quantification of liberated 7-amino-4-methvlcoumarin. Standard curves relating fluorescence
emitted at 460 nm to the concentration of liberated 7-amino-4-methylcoumarin were
constructed on the basis of the micro and macro assays. In each case dist.H2O was used in
place of the enzyme sample. The buffer/activator/dist.H2O mixture was pre-incubated at 37°C
for 2 min. An appropriate dilution of the standard 7-amino-4-methylcoumarin solution was
added, in place of the substrate solution, and the fluorescence of the solution was determined
after 10 min at 37°C. In each case, linear regression analysis of the curves showed a strong
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correlation with r of 0.991 and 0.996 for the micro and macroassay respectively. The
following standard curves were determined using the results obtained from the assays:
x = (y - 48.614)/0.181 for the microassay
x = (y - 8.609)/0.536 for the macroassay
where x = concentration (n moles) of 7-amino-4-methylcoumarin, and y = fluorescence of the
solution.
3.2.2 Azocasein assay
An attempt was made to develop a protocol that allowed the co-purification of a related
protease, cathepsin L, during the cathepsin B isolation. Although this attempt was
unsuccessful, aspects of the co-purification protocol, and assays employed, are described
because of their possible application in future studies.
Azocasein is a casein derivative in which the tyrosyl and histidyl side-chains have been
coupled with diazotized sulfanilic acid or sulfanilamide in an alkali medium. Proteolytic
cleavage of the azocasein generates peptides which are TCA-soluble. The azo-coupling
confers an intense yellow colour to these peptides which can be quantified by their A,34. This
assay can be made specific for cathepsin L by including 3 M urea and pepstatin into the
assay. Whilst cathepsin L is stable in 3 M urea, these conditions should denature
cathepsin B. Pepstatin was also included in the assay buffer to inhibit cathepsin D (Barrett
and Kirschke, 1981).
3.2.2.1 Reagents
Buffer/activator F340 mM Na-acetate. 4 mM EDTA. 1 fig/ml pepstatin. 0.02% NaN,. 8 mM
DTT.pH5.01. Glacial acetic acid (9.72 ml), EDTA (0.744 g), NaN3 (0.1 g) and pepstatin
(0.5 mg) were dissolved dist.H2O, adjusted to pH 5.0 with NaOH and made up to 500 ml.
DTT (6.2 mg/5 ml) was added to the buffer just before use.
6% (m/v) Azocasein. Azocasein (3 g) was weighed into a glass beaker and dissolved in
50 ml dist.H2O with gentle magnetic stirring at room temperature for about 1 h.
Azocasein/3M urea solution. Urea (54 g) was dissolved in 6% azocasein solution (50 ml) by
magnetic stirring, and made up to 150 ml with dist.H2O.
5% (m/v) TCA. TCA (25 g) was dissolved in 500 ml of dist.H2O.
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3.2.2 .2 Procedure
Enzyme sample (200 ul) and buffer/activator (200 ul) were mixed and incubated at 37°C for
5 min to activate the proteases. Azocasein/urea (400 ul) was added to this solution and a
sample (200 ul) of the mixture was immediately withdrawn, and mixed with 5% TCA in a
polyethylene microfuge tube. This served as zero time control for the reaction. After 30 min,
a further sample was withdrawn and mixed with 5% TCA (1 ml). The samples in the 1.5 m]
microfuge tubes were centrifuged in a Sigma mini-centrifuge ( 12 000 x g, 5 min, RT) to
precipitate undigested azocasein. The A334 of the supernatants were read in glass micro-
cuvettes with blacked-out sides
3.2.3 Optimisation of TPP cuts for cathepsin B in bovine liver.
In the protocol developed by Meinesz (1996), the TPP cut of 30-40 % resulted in a loss of
yield of ca. 99% and a purification of only 4.2-fold. Whilst this cut allowed for the rapid
isolation of electrophoretically pure cathepsin B, the amount of enzyme produced per
isolation would have been insufficient for the purposes of the present study. Consequently it
was necessary to reinvestigate the TPP fractionation step in order to determine an optimal cut.
3.2.3.1 Reagents
Homogenisation buffer [50 mM Na-acetate. 150 mM NaCl. 1 mM Na.EDTA. 0.02% NaN:.
pH 4.51. Glacial acetic acid (2.86 ml), NaCl (8.77 g), Na.EDTA (0.37 g) and NaN, (0.2 g)
were dissolved in 950 ml dist.H2O, adjusted to pH 4.5 with NaOH, and made up to 1 litre.
Buffer A T20 mM Na-acetate. 1 mM Na2EDTA. 0.02% NaN:. pH 5.01. Glacial acetic acid
(2.29 ml), Na2EDTA (0.74 g) and NaN3 (0.4 g) were dissolved in 1.9 litres of dist.H2O.
adjusted to pH 5.0 with NaOH, and made up to 2 litres.
Bovine liver. Fresh bovine liver was obtained from the Cato Ridge Abattoir. The liver was
diced into 2 x 2 cm cubes and frozen at - 70°C. Liver was frozen for at least 3 days, but no
longer than a month, before use.
3.2.3.2 Procedure
Bovine liver was allowed to thaw overnight (12 h) at 4°C to effect release of lysosomal
hydrolases from their endocytic compartments. The liver was homogenised in
homogenisation buffer at a ratio of 1:1 (liver mass to buffer) in a Waring blendor (max.
speed, 3 mm/100 g of tissue), and centrifuged (9000 x g, 20 min, 4°C) to remove any
undissolved material. The supernatant was collected and adjusted, with magnetic stirring, to
pH 4.2 using glacial acetic acid. This step is important in removing cytosolic inhibitors of the
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cathepsins. The solution was cenlrifuged (9000 x g, 20 min, 4°C) to remove acid-
precipitated protein, and TPP was effected on the supernatant as described in Section 2.6.
An initial ammonium sulfate cut of 10% (m/v) was used, the precipitate being collected and
dissolved in buffer A (50 ml). Empirically it was found that the 10% (m/v) ammonium
sulfate cuts were heavily contaminated with cellular debris and this cut was therefore not
analysed further. Further cuts with 5% (m/v) increments of ammonium sulfate were made to
the solution. The precipitates at each step were collected and dissolved in buffer A (50 ml).
These solutions were assayed for protein content by the Bradford assay (Section 2.2.1) and




10-15% 15-20% 20-25% 25-30% 30-35%
TPP cuts of acid supernatant (% ammonium sulfate)
Figure 4. Optimal ammonium sulfate cuts for the isolation of cathepsin B.
As described in Section 3.2.3.2 an acid supernatant was fractionated using
5% ammonium sulfale cuts. The precipitate from each cut was assayed
using CBz-R-R-AMC (O), CBz-F-R-AMC (•) and azocasein ( • ) . The data
represents mean ± s.d. (n=3).
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3.2.3.4 Discussion
Judging by the hydrolysis of the substrate CBz-R-R-AMC, it appears that most of the
cathepsin B precipitates in the 10-25% ammonium sulfate cut during TPP (Fig. 4). The 25-
40% ammonium sulfate cut yields pure cathepsin B, but the yield obtained using this cut was
significantly less than in the 10-25% cut (data not shown). When the substrate CBz-F-R-
AMC was used, two distinct peaks of activity in the 15-20 % and 20-25% cuts, were
obtained. The first peak optimum at 15-20% corresponds closely with the pattern of
hydrolysis by cathepsin B of the substrate CBz-R-R-AMC. The second peak optimum
probably falls in the 20-25% region and is responsible for the plateau shape of the CBz-F-R-
AMC curve. This suggests that cathepsin L precipitates at higher ammonium sulfate
concentrations (15-30%) than cathepsin B during TPP.
These results were confirmed using an azocasein assay, in the presence of 3 M urea. This
assay revealed that maximum hydrolysis of the azocasein substrate occurred in the 15-20%
ammonium sulfate cut, the same region where cathepsin B is optimally precipitated. This
suggests that cathepsin B may be able to cleave azocasein even in the presence of 3 M urea.
Whilst pure cathepsin B is sensitive to 3 M urea (Khan et al., 1992), a membrane associated
cathepsin B in fibroblasts and melanoma cells was shown to be insensitive to the urea (Mayer
etal., 1997). Whilst most membranes are expected to partition into the tertiary butanol phase
during TPP, a possible explanation for the apparent insensitivity of cathepsin B to urea
insensitivity could be the association of the enzyme with other cellular components present in
a crude mixture.
3.2.4 Isolation of bovine cathepsin B.
Cathepsin B is ubiquitously distributed and has been isolated from a vaiiety of tissue sources.
The following schemes highlight some of the tissue sources, isolation procedures and yields
used to obtain pure cathepsin B. A distinction is made between the total amount of enzyme
recovered (mg/kg of starting material), and the total amount of activity recovered (yield),
from a purification.
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Scheme I (Barrett and Kirschke, 1981)
Step. Procedure





5 Chromatography on DEAE cellulose
6 Chromatography on Aminophenylmercuric acetate-
Sepharose
Yield 60 mg/kg
Scheme II (Willenbrock and Brocklehurst, 1985a)
Step Procedure
Starting material Bovine spleen
1 Homogenisation
2 Acid precipitation overnight
3 Ammonium sulfate precipitation
4 Dialysis and concentration
5 Sephadex G-75 chromatography
6 Thiol addition and desalting
1 Thiopropyl-Sepharose 6B affinity chromatography
8 CM cellulose cation exchange chromatography
Yield No yield recorded
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0.64 mg/kg of tissue, 21.1 % yield
Scheme IV (Rich et al, 1986)
Step Procedure






Yield 17.33 mg/kg of tissue, 171% yield
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Scheme V (Deval etal, 1990)
Step Procedure





5 Sephadex G-75 chromatography
6 Mono-S chromatography
7 Organomercurial-Sepharose chromatography
Yield 0.6 mg/kg of tissue, 3.9% yield
Scheme VI (Meinesz, 1996)
Step Procedure




4 S-Sepharose cation exchange chromatography
5 Sephacryl S-100 chromatography
6 Hydroxyapatite chromatography
Yield 0.00689 mg/kg, 0.05% yield
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Cathepsin B has been cloned and expressed in yeast. Two schemes (VII and VIII) describing
the purification of the protease are described below:
Scheme VII (Illy etal, 1997)
Step Procedure
Starting material Bovine liver
1 Cathepsin B expressing clone of E. coli
1 Transformation into Pichia pastoris GS 115
3 Induction of expression of recombinant enzyme
4 Harvest and concentration of culture supernatant
5 Dialysis
6 S-Sepharose or Sephacryl S-200 HR
Yield 20 mg/litre of culture medium
Scheme VIII (Bjork et al., 1994)
Step Procedure
Starting material Bovine liver
1 Cathepsin B expressing clone of E. coli
2 Transformation into yeast (species not given)
3 Induction of expression of recombinant enzyme




Yield 2.2 mg/iitre of culture medium
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Meinesz (1996) developed a cost-effective and rapid isolation procedure for cathepsin B from
bovine spleen (Scheme VI). Electrophoretically pure enzyme could be obtained within 48 h,
using readily available chromatographic media. However, the yield of enzyme obtained was
very low, especially compared to the protocol of Rich et al. (1986) (Scheme IV) which uses
Sepharose-Ahx-Gly-Phe-GlySc affinity chromatography. The Sepharose-Ahx-Gly-Phe-
GlySc affinity chromatography gel is no longer commercially available, however, and its
synthesis is expensive and technically complex. The other procedures described may also
give higher yields of enzyme, but at the cost of time (Schemes I-III, V), expense (Scheme I,
III, IV and V) or technical complexity (Schemes VII and VIII). Consequently in this study
an attempt was made to modify the procedure of Meinesz (1996), with its advantages of
convenience, low cost and simplicity, to give improved yields of enzyme .
3.2.4.1 Reagents
Homogenisation buffer T50 mM Na-acetate. 150 mM NaCl. 1 mM Na.EDTA. 0.02% NaN:,
pH 4.51. Glacial acetic acid (2.86 ml), NaCl (8.77 g), Na,EDTA (0.37 g) and NaN, (0.2 g)
were dissolved in 950 ml dist.H2O, adjusted to pH 4.5 with NaOH and made up to 1 litre.
Buffer A T20 mM Na-acetate. 1 mM NeuEDTA. 0.02% NaN:. pH 5.01. Glacial acetic acid
(2.29 ml), Na2EDTA (0.74 g) and NaN3 (0.4 g) were dissolved in 1.9 litres of dist.H2O,
adjusted to pH 5.0 with NaOH and made up to 2 litres.
Buffer B 1100 mM Na-acetate. 500 mM NaCl. 1 mM Na^EDTA. 0.02% NaN3. pH 5.51.
Glacial acetic acid (11.44 ml), NaCl (58.44 g), NajEDTA (0.74 g) and NaN3 (0.4 g) were
dissolved in 1.9 litres of dist.H2O, adjusted to pH 5.5 with NaOH and made up to 2 litres.
Buffer Cl II mM Na-phosphate. 1 mM Na2EDTA. 0.02% NaN3. pH 6.81. NaH2PO4.H2O
(0.159 g), NajEDTA (0.37 g) and NaN3 (0.2 g) were dissolved in 950 ml of dist.H2O,
adjusted to pH 6.8 with NaOH and made up to 1 litre.
Buffer C2 110 mM Na-phosphate. 1 mM Na,EDTA. 0.02% NaN3. pH 6.81. NaH2PO4.H,O
(0.793 g), Na2EDTA (0.185 g) and NaN3 (0.1 g) were dissolved in 450 ml of dist.H,O,
adjusted to pH 6.8 with NaOH and made up to 500 ml.
Buffer C3 T300 mM Na-phosphate. 1 mM Na.EDTA. 0.02% NaN:. pH 6.81.
NaH2PO4.H2O (23.80 g), Na2EDTA (0.185 g) and NaN3 (0.1 g) were dissolved in 450 ml
of dist.H2O, adjusted to pH 6.8 with NaOH and made up to 500 ml.
"Buffer" D H mM MgCL. 1 mM Na,EDTA. 0.02% NaN:1. MgCl2.6H2O (0.218 g),
Na2EDTA (0.185 g) and NaN3 (0.1 g) were made up to 500 ml with dist.H,O.
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"Buffer E" II M NaCl, 1 mM Na^EDTA. 0.02% NaNJ. NaCl (29.22 g), Na,EDTA
(0.185 g) and NaN3 (0.1 g) were made up to 500 ml with dist.H2O.
S-Sepharose fast flow. The S-Sepharose cation-exchanger was prepared by diluting the
supplied hydrated gel 1:2 (v:v) with buffer A, and packing the resulting slurry into a glass
column under gravity. The column bed was initially regenerated with 2 M NaCl in buffer A.
The same buffer was used to regenerate the column between purification procedures. The
column was equilibrated before use by washing with 5 column volumes of buffer A.
Biogel P-60. The Biogel P-60 gel was made by hydrating the xerogel with buffer A (11 ml
per gram of gel). The column bed was initially regenerated using 5 column volumes of
buffer B. In between purification procedures the column was re-equilibrated with 2 column
volumes of buffer B. The gel was calibrated using the molecular weight standards, blue
dextran (>2 000 kDa), ovalbumin (45 kDa), carbonic anhydrase (30 kDa), myoglobin
(18.8 kDa) and cytochrome C (12.38 kDa).
Hydroxyapatite. The hydroxyapatite resin was prepared according to the manufacturer's
instructions. The hydroxyapatite gel was mixed with 2 volumes of buffer Cl and left to settle
into two distinct phases. After 10 min, the upper layer, containing any fines that may have
been generated during handling, was removed and replaced by 2 more volumes of buffer C1.
This procedure was repeated. These wash steps are necessary because the brittle nature of
the hydroxyapatite crystals often results in the generation of fines that can block columns.
The remaining slurry was packed into a glass column under gravity. The column was
regenerated and equilibrated with five column volumes of buffer Cl.
Bovine liver. Fresh bovine liver, obtained from the Cato Ridge Abattoir, was diced into 2 x
2 cm cubes and frozen at -70°C for at least 3 days, but no longer than a month, before use.
3.2.4 .2 Procedure
Bovine liver was homogenised and acid precipitated as described in Section 3.2.3.2. The
acid supernatant was subjected to TPP (Section 2.6.1) using an ammonium sulfate cut of 10-
25%. The TPP precipitate was dissolved in buffer A at 1/10 the volume of the acid
precipitate, This sample was loaded directly onto an S-Sepharose column (2.5 x 17.5 cm =
85.9 ml), equilibrated with buffer A, at 10 cm h'1. Cathepsin B was eluted with a gradient of
70-200 mM NaCl in buffer A. Active fractions, which eluted between 90-150 mM NaCl,
were pooled and dialysed against sucrose to a volume of approximately 1-5%' of the volume
of the molecular exclusion gel. These fractions were loaded onto a Biogel P-60 column (2.5
x 91.5 cm = 444.9 ml) and run at 5 cm h'1. Active fractions were analysed by SDS-PAGE
(Section 2.4) and silver staining (Section 2.5) to determine their purity.
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If these fractions were not pure they were pooled and dialysed against several changes of
buffer Cl. The pooled fraction was applied to a hydroxyapatite column (1.5 X 7.7 cm =
13.6 ml), equilibrated with buffer Cl, at 5 cm h'1. Cathepsin B was purified using a scheme
devised by Gorbunoff (1985). This scheme allows for the separation of basic, neutral and
acidic proteins using the principles described in Section 2.7. Basic proteins were eluted by
washing the column with two volumes of "buffer" D. Neutral proteins were then eluted by
washing the column with two volumes of "buffer" E. Cathepsin B, which elutes in the acid
fraction, was eluted using a gradient of 10-300 mM NaH2PO4 (buffer C2 and buffer C3).
Purity of the active fractions was assessed by SDS-PAGE (Section 2.4) and silver staining
(Section 2.5).
3.2 .4 .3 Results and discussion
Table 2. The purification of cathepsin B from bovine liver
Total Total Specific Purification Yield
protein activity activity (%)
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Figure 5. Chromatography of the pH 4.2 TPP fraction of cathepsin B On
S-Sepharose.
Column 2.5 x 17.5 cm (85.9 ml bed volume), equilibrated in 20 mM Na-
acetate, pH 5.0, containing 1 mM Na2EDTA, 0.02% NaN3, a 70-200 mM
NaCl gradient was applied at I; flow rate 10 cm h'1; fractions, 8.3 ml. (-•-)
A28O, (-O-) cathepsin B activity, (l-l) pooled fraction.
The modifications introduced into the protocol of Meinesz (1996) resulted in an improved
cathepsin B yield of 4.46% compared to the 0.05% obtained with the original protocol.
Whilst the yield obtained by this method is significantly less than that obtained by Rich et al.
(1986) and Barrett and Kirschke (1981), its relative convenience, cost-effectiveness and
simplicity make it an attractive alternative to these methods. This method proved to be better
than the methods described by Deval etal. (1990) and Bradley and Whitaker (1986) in terras
of the amount of purified enzyme obtained per kg of starting material and the simplicity of
procedure.
The first modification made was at the TPP level. An ammonium sulfate cut of 10-25%
(Section 3.2.3) was used during TPP, rather than the 30-40% and 25-40% ammonium
sulfate cuts described by Meinesz (1996). This change results in a different profile of
proteins being included in the TPP cut, necessitating changes in the downstream purification
procedures. The general applicability of this method was emphasised by the fact that
cathepsin B could be purified from a 25-40% cut with a yield of 0.48% (data not shown).
Thus pure enzyme could be obtained using a 10-25% and a 25-40% ammonium sulfate TPP
M
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Figure 6. Chromalography of pH 5.0 S-Sepharose fraction on Biogel P-60.
Column, 2.5 x 91.5 cm (445 ml bed volume); buffer, 100 mM Na-acetate,
pH 5.5, containing 500 mM NaCl, 1 mM Na2EDTA, 0.02 % NaN3; flow
rate 5 cm h'1; and fractions 5 ml. (-•-) A^, (-<>-) cathepsin B activity.
Fraction purity was assessed by SDS-PAGE and pooled accordingly.
This success of this purification procedure hinges largely on the performance of the S-
Sepharose cation exchanger. As described by the increase in specific activity at this stage
(Table 2), the S-Sepharose cation exchanger is responsible for removing a large proportion of
the contaminants that could co-elute with cathepsin B in the molecular exclusion step
following cation exchange chromatography. It was found that the profile of proteins coming
off the cation exchanger was affected by the tissue batch and amount of tissue used, as well
as slight changes in the homogenisalion and acid precipitation steps. An advantage of
methods that use affinity chromatography (see Schemes I-VI, Section 3.2.4) is that they are
not as susceptible to changes in upstream methods. In order to counter this effect, two
further changes were made to the original procedure. Cathepsin B was eluted off the S-
Sepharose cation exchanger with a shallower salt gradient of 70-200 mM NaCl in buffer A
(Fig.. 5). This gradient allowed for greater selectivity in choosing fractions used for
subsequent purification steps. An additional downstream step, using hydroxyapatite
chromatography to purify contaminated fractions, was also introduced.
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An attempt was made to co-purify cathepsin B and cathepsin L. It was envisaged that a 10-
30% ammonium sulfate cut during TPP would be sufficient to harvest both enzymes (Section
3.2.3). Following TPP, the precipitate was loaded onto the S-Sepharose cation exchanger
and cathepsin B eluted as described above. Cathepsin L, which binds to the column with
greater affinity, was eluted with a gradient of 200-700 mM NaCl in buffer A (data not
shown). However, the altered protein profile produced by the new 10-30% ammonium





Figure 7. Tris-tricine SDS-PAGE of cathepsin B isolated from bovine liver.
Pure cathepsin B fractions from the P-60 column were boiled in reducing
treatment buffer and loaded onto a 10% tricine gel (lane 2). MW markers
(phosphorylase b, 94 kDa; BSA 68 kDa; ovalbumin, 45 kDa; carbonic
anhydrase, 30 kDa; trypsin inhibitor, 20.1 kDa; lysozyme, 14 kDa) are
indicated in lane 1.
A Biogel P-60 molecular exclusion gel was used to purify cathepsin B from fractions pooled
at the S-Sepharose step (Fig. 6). Biogel P-60 was used in place of the Sephacryl S-100 gel
used by Meinesz (1996) because of the presence of a contaminating protein of approximately
70 kDa that could not be satisfactorily resolved using the Sephacryl gel. This contaminating
band was precipitated in the 10-25% ammonium sulfate TPP cut, but did not appeal- in the
25-40% TPP cut (data not shown). Although a single chain enzyme is indicated in Fig. 7,
both single and two-chain forms of cathepsin B were obtained during the purification.
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If the cathepsin B fractions appearing after molecular exclusion were still contaminated they
were chromatographed on hydroxyapatite as described above. This additional procedure
poses the question as to why hydroxyapatite was not used directly after S-Sepharose cation
exchange chromatography. The answer is that the brittle nature of the hydroxyapatite gel and
its low binding capacity made it most suitable only for a final step.
3.2.5 Active site titration of cathepsin B using E-64
Active site titration of cathepsin B was undertaken in order to determine the percentage of
active enzyme present in an isolated sample. Trans-epoxysuccinyl-leucylamido(4-guanidino)
butane, or E-64, is a powerful irreversible inhibitor of cysteine proteinases that was originally
isolated from Aspergillus japonicus (Hanada et ai, 1978). E-64 binds to cathepsin B in a
1:1 molar ratio. Thus the concentration of active cathepsin B can be determined from the
minimum concentration of E-64 required to completely abolish enzyme activity (Barrett and
Kirschke, 1981).
Figure 8. The structure of trans-epoxysuccinyl-leucylamido(4-guanidino)
butane (E-64).
The C2 position is the site for the formation of the irreversible thioether
bond between E-64 and cathepsin B.
E-64 binds to the S subsites of the enzyme and nucleophilic attack by the active site thiol on
the oxiranc ring at the C2 position of the inhibitor results in the formation of an irreversible
thioether bond. The binding of E-64 and E-64 analogues to the active site of cathepsin B
shows a marked pH and ionic strength dependence. The binding of the inhibitor is more
effective at lower pH possibly due to the interaction of the carboxylate group of the inhibitor
with the two protonated histidine residues (110 and 111) of the occluding loop. High ionic
strength conditions, in the region of 50-150 mM NaCl, disrupt the electrostatic interactions
of the inhibitor with the S subsites of the enzyme. The sensitivity of the enzyme to these
conditions could account for the differences in kinetic constants obtained in different
laboratories (Schaschke et al., 1997). The pH and ionic conditions used in this active site
titration were as described by Barrett and Kirschke (1981).
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Active site titration was routinely used to determine the absolute concentration of enzyme
used in the assays described in Chapter 4, as well as to monitor changes in enzyme activity
during enzyme storage.
3.2.5.1 Reagents
Buffer/activator [0.1 M Na-phosphate, 4 mM Na3EDTA, 0.02% NaN,. 5 mM dithiothreitol,
pH 6.01. NaH2PO4 (6.90 g), NajEDTA (0.93 g) and NaN3 (0.1 g) were dissolved in 450 ml
dist.H,O, adjusted to pH 6.0 with NaOH and made up to 500 ml. Immediately before use,
dithiothreitol was added to 5 mM (i.e. 0.51 g/500 ml)
1 mM CBz-R-R-AMC substrate stock solution. CBz-R-R-AMC (3.1 mg) was dissolved in
DMSO (5 ml), divided into 100 ul aliquots and stored at -4°C. When required, this stock was
diluted in dist.H2O to a working concentration of 40 uM .
10 mM E-64 stock solution. E-64 (1.8 mg) was dissolved in DMSO (500 ul). Suitable
dilutions of the inhibitor were made in Ultrapure Milli-Q water. The dilutions used were
based on the concentration of the isolated enzyme (a M, of 28 000 was assumed for
cathepsin B).
3.2 .5 .2 Procedure
The active site titration of cathepsin B was adapted from Barrett and Kirschke (1981).
Enzyme sample (25 ul), buffer/activator (50 ul) and an appropriate dilution of E-64 were
incubated at 37°C for 30 min to allow the binding reaction to go to completion. AH reactions
were carried out in triplicate. After 30 min, aliquots from each tube was assayed (Section
3.2.1) and a graph of activity versus E-64 concentration constructed. The absolute
concentration of active enzyme (Eo) was detentiined from the intersection of the graph with
the E-64 concentration axis.
3.2.5 .3 Results
Using active site titration, the absolute concentration of isolated enzyme was calculated to be
1.58 |JM. This represents 30% of the purified sample.
3.3 Cathepsin D
The human cathepsin D gene is expressed in nearly all mammalian tissues. The gene has
been localised to chromosome 11 (Hasilik et al., 1982) and is organised into 9 exons and 8
introns (Redecker et al, 1991). The upstream regulatory sequences of the gene lack TATA
and CCAAT boxes, and contain a CpG island and Spl binding sites. These features are
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consistent with those of a housekeeping gene, and are responsible for the nearly ubiquitous
expression of the gene (Redecker et al, 1991). Transcription of the cathepsin D gene can be
induced by estrogens in MCF-7 (Cavailles et al, 1989) and ZR-75 (Westley and May, 1987)
breast cancer cells. Expression of the gene can also be induced in U-937 monocytes by
calcitriol, although it is unlikely that calcitriol directly affects the gene (Redecker et al, 1989).
Several hormone response elements have been described for the cathepsin D gene and these
may be responsible for the regulation of gene expression (Redecker et al, 1991).
Cathepsin D mRNA is translated into a prepropeptide. The signal sequence is cleaved co-
translationally and the enzyme folds into its proenzyme confonnation within the ER lumen.
The propeptide, which prevents improper activation of cathepsin D, is necessary for the
enzyme to assume its correct conformation. Cathepsin D deletion mutants lacking the
propeptide do not assume the native conformation and are rapidly degraded in a chloroquine-
independent fashion (Conner, 1992). Cathepsin D is folded into 3 domains typical of
aspartic proteases: an N-terminal domain, a C-terminal domain and an interdomain anti-
parallel |3-pleated sheet. The interdomain region is made up of the first 7 amino acids of the
N-terminal domain (residues 1-7 of the mature human enzyme), the last 16 residues of the C-
terminal domain (residues 330-346) and interdomainal linking residues (160-200). The
interdomain region forms an active site cleft in which the active site residues Asp-33 and
Asp-231 are found, midway. A conformationally flexible (3-hairpin structure known as the
'flap' region (residues 72-87), lies above the active site (Baldwin et al., 1993).
Cathepsin D has two N-linked glycosylation sites, one on each domain. Like other
lysosomal enzymes, these oligosaccharides are modified by the addition of phosphate
monoesters to the mannose residues on the oligosaccharide chain. This modification allows
cathepsin D to be transported to the endosomal system by the mannose 6 phosphate receptor
system (MPR). Elimination of these glycosylation sites in human fibroblasts results in
cathepsin D mutants that are stable, but are not secreted, and are poorly targeted to the
lysosome (Fortenberry et al, 1995). In contrast to these results, MPR-independent
membrane association and/or transport of cathepsins B and D has been described in rat
hepatocytes (Authier et al, 1995) and for procathepsins D and L in macrophages (Diment
etal, 1988), Hep G2 cells (Rijnbout et al, 1991a; 1991b) and mouse fibroblasts (Mclntyre
and Erickson, 1991:1993). This discrepancy in the results obtained suggests that MPR-
independent transport systems may be cell specific.
Upon delivery to the endosomal system, procathepsin D is proteolytically processed to a
mature enzyme. In rat, mouse and hamster tissue the enzyme is processed to a single chain
enzyme, whilst in human and porcine tissue cathepsin D is ultimately processed to a 2 chain
form. Bovine tissue contains equivalent amounts of both forms of the enzyme (Conner
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et ai, 1989). Procathepsin D is processed to a 44 kDa single chain enzyme in a
prelysosomal endocytic compartment (Rijnboutt etal, 1992).
The 55 kDa proenzyme can undergo acid-dependent autocatalytic processing to generate
pseudocathepsin D in vitro . Low pH causes the local denaturation of the propeptide at the
active site of the proenzyme. This allows for limited processing of procathepsin D to
generate pseudocathepsin D whose size is intermediate between 55 kDa procathepsin D and
the 44 kDa single chain enzyme (Conner, 1989). The existence of pseudocathepsin D
in vivo has been disputed by Richo and Conner (1994). They generated cathepsin D mutants
which were incapable of autocatalytic processing in vitro, but were still routed to the
lysosome and processed to mature enzyme in mouse cells. These results suggest that
pseudocathepsin D is not a normal intermediate of cathepsin D processing in vivo. In
contrast, the gastric aspartic proteinases, pepsinogen, progastricsin and prochymosin appear
to be activated by both inter- and intra-molecular proteolytic cleavages (Richter et al, 1998)
The 44 kDa single chain enzyme can, depending on the species concerned, be processed into
a 2-chain form. The light (15 kDa) and heavy chains (30 kDa) of the 2-chain enzyme are
non-covalently associated (Baldwin et al., 1993). The significance of this proteolytic
cleavage has not been determined. Cathepsin D processing, from the proenzyme to mature
cathepsin D, may be carried out by cysteine proteases. Inhibition of cysteine proteases in
cultured cells prevents cathepsin D maturation (Rijnboutt et al, 1991b). Processing of the
enzyme begins pre-lysosomally but is completed within the 'lysosome' itself (Rijnboutt
etal., 1992).
3.3.1 Cathepsin D assay
The haemoglobin assay developed by Anson (1939) was used in this study to measure the
activity of cathepsin D. Cathepsin D hydrolysis of haemoglobin generates TCA-soluble
peptides which can be determined spectrophotometrically. Synthetic substrates have been
developed for cathepsin D. These substrates have been found to be relatively insensitive
(Pohl et al, 1983) or, in the case of the substrate F-A-A-F(NO2)-F-V-L-OM4P (Agarwal and
Rich, 1983), too expensive. During this study an attempt was made at using fluorescein-
haemoglobin as a substrate (De Lumen and Tappel, 1970). This was expected to be a trade-
off between the synthetic and the native haemoglobin assays. However, the rapid quenching




5% (m/v) Haemoglobin substrate. Bovine haemoglobin powder (0.5 g) was dissolved in
dist.H2O (10 ml) with magnetic stirring.
Assay buffer r250 mM sodium citrate. 0.02% NaN3. pH 3.21. Citric acid (26.3 g) and NaNL
(0.1 g) were dissolved in about 450 ml of dist.H2O, adjusted to pH 3.2 with NaOH and
made up to 500 ml.
5% (m/v) Trichloroacetic acid. Trichloroacetic acid (5 g) was dissolved in dist.H2O and
made up to 100 ml.
3.3 .1 .2 Procedure
Enzyme sample (26 |il), assay buffer (506 ul) and substrate (133 ul) were mixed together in a
polyethylene microfuge tube and incubated at 37°C for 30 min. After 30 min, a sample
(300 ul) was removed and added to polyethylene microfuge containing TCA (240 ul). A
reaction blank was created by replacing the enzyme sample with dist.H2O (26 ul). Insoluble
protein was precipitated by centrifugation on a bench-top microfuge (48 x g, 5 min, RT).
The absorbance of the reaction mixture supernatant was read against the blank supernatant in
a 1 ml quartz cuvette at 280 nm. In this study, one unit of enzyme activity was defined as the
quantity of enzyme producing an increase in absorbance of 1.0 in excess of the control in
60 min.
3.3 .2 TPP optimisation for cathepsin D purification from bovine liver.
Previous cathepsin D isolations undertaken in this laboratory from bovine, porcine and
human spleens have used an optimal TPP cut of 20-35% ammonium sulfate (Fortgens,
1996). However, an optimal TPP cut has not been described for bovine liver cathepsin D.
In order to determine this cut, a TPP optimisation was undertaken along similar lines to that
described for cathepsin B (Section 3.2.3).
3 .3 .2 .1 Reagents
Loading buffer r50 mM Na-acetate. 200 mM NaCl. 0.02% NaN3, pH 3.51. Glacial acetic
acid (2.86 ml), NaCl (11.69 g) and NaN3 (0.2 g) were dissolved in 900 ml of dist.H2O,
titrated to pH 3.5 with NaOH and made up to 1 litre.
Elution buffer L50 mM Tris-HCl. 200 mM NaCl. 0.02% NaN:. pH 8.51. Tris (6.06 g),
NaCl (11.69 g) and NaN3 (0.2 g) were dissolved in 900 ml of dist.H2O, titrated to pH 8.5
with HC1 and made up to 1 litre.
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Bovine liver. Bovine livers were prepared as described in Section 3.2.3.1.
3.3.2.2 Procedure
Bovine livers were allowed to thaw overnight (12 h) at 4°C to effect the release of cathepsin D
from the endosomal-lysosomal system. These livers were homogenised in cold dist.H2O at a
ratio of 1:2 (liver mass to dist.H2O) using a Waring Mendor (max. speed, 3 min/100 g liver
tissue). Undissolved protein was removed by centrifugation (10 000 x g, 30 min, 4°C) and
the supernatant poured off. The pH of the supernatant was adjusted to pH 3.2 with HC1 with
constant stirring. Precipitated protein was removed by centrifugation (10 000 x g, 30 min,
4°C) and TPP effected on the supernatant (Section 2.6) using a 10% ammonium sulfate cut.
Empirically it was found that the 10% ammonium sulfate precipitate had a low specific
activity and was discarded. Further ammonium sulfate cuts in 10% increments were effected
on the supernatant. The precipitates from each cut were assayed using the cathepsin D assay
(Section 3.3.1).
3.3.2.3 Results and Discussion
10-20% 20-30% 30-40% 40-50%
TPP fractionalion of acid supernatant (% ammonium sulfate)
Figure 9. Optimal ammonium sulfate cuts for the isolation of cathepsin D.
As described in Section 3.3.2.2 an acid supernatant was fractionated using
10% ammonium sulfate cuts. The precipitate from each cut was assayed
using haemoglobin.
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The optimal TPP cut for the isolation of catliepsin D from bovine liver was between 20-35%
ammonium sulfate (Fig. 9).
3 . 3 . 3 Purification of cathepsin D
Most cathepsin D isolations centre on affinity chromalography steps that allow for the rapid
isolation of the protease, preventing autolysis and auto-inactivation. Various affinity
chromatography ligands have been used for the isolation of cathepsin D including pepstatin
(Conner, 1989; Jacobs et al., 1989), a combination of pepstatin and concanavalin A ligands
(Tanji et al., 1991), haemoglobin (Smith and Turk, 1974) and rabbit anti-cathepsin D IgG
(Babnik et al., 1984). The isolation used in this study was based on the method of Jacobs
et al. (1989). This method takes just 6 h and allows for the isolation of cathepsin D from
bovine spleen with a yield of ca. 8%. This method has essentially two steps: TPP and
affinity chromatography on pepstatin-Sepharose. TPP has been described in detail above
(Section 2.6). An important property of TPP, that is especially relevant in this isolation, is
the denaluration of many oligomeric proteins by the process. TPP causes the denaturation of
haemoglobin, which as can be expected (Section 3.3.1), can be a major contaminant in
cathepsin D isolations.
Figure 10. The structure of Isovaleryl-Val-Val-Sta-Ala-Sta (pepstatin A)
The pepstatin-cathepsin D complex is stabilised by hydrogen bond interactions between the
main chain atoms of the inhibitor and the side chain and main chain atoms of the enzyme.
The central statine residue is a Pl-Pl1 dipeptide isostere of Leu-Gly in which there is no P 1 '
side-chain substituent (Fig. 10). This dipeptide isostere mimics a tetrahedral intermediate in
peptide bond hydrolysis by cathepsin D, and is largely responsible for the affinity of
cathepsin D for pepstatin (Baldwin et al., 1993; Szewczuk et al., 1992).
The binding of cathepsin D to pepstatin, which depends on hydrogen bond interactions, is
reversible and is inefficient at neutral pH values (Knight and Barrett, 1976). By raising the
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pH, the pepstatin-cathepsin D interaction can be disrupted, allowing the enzyme to be eluted
off a pepstatin affinity column.
3.3.3.1 Reagents
Loading buffer [50 mM Na-acetate. 200 mM NaCL 0.02% NaN3. pH 3.51. Acetic acid
(2.86 ml), NaCl (11.69 g) and NaN3 (0.2 g) were dissolved in 900 ml of dist.H,O, titrated to
pH 3.5 with NaOH and made up to 1 litre.
Elution buffer T50 mM Tris-HCl. 200 mM NaCl. 0.02% NaN:. pH 8.51. Tris (6.06 g),
NaCl (11.69 g) and NaN3 (0.2 g) were dissolved in 900 ml of dist.H2O, titrated to pH 8.5
with HC1 and made up to 1 litre.
Bovine liver. Bovine livers were prepared as described in Section 3.2.3.1.
Pepstatin-diaminohexane-Sepharose. Preparation of this gel is described in Section 2.8.
3.3 .3 .2 Procedure
Bovine liver was allowed to thaw overnight (12 h, 4°C) and homogenised in a Waring
blendor (max. speed, 3 min/100 g of tissue) with cold dist.H2O in a ratio of 1:2 (liver mass to
volume of dist.H2O). This ratio of 1:2 (liver mass to volume of dist.H2O) was found to give
a better recovery of enzyme than a ratio of 1:1 as used by Fortgens (1996). The homogenate
was centiifuged (10 000 x g, 30 min, 4°C) to remove any undissolved debris and the
supernatant decanted. The pH of the supernatant was adjusted to pH 3.2 using HC1 with
constant stirring. Acid precipitated material was removed by centrifugation (10 000 x g,
30 min, 4°C). The supernatant was subjected to TPP (Section 2.6) using an ammonium
sulfate cut of 20-35% (Section 3.3.2). The TPP precipitate was dissolved in loading buffer
(Section 3.3.3.1) at approximately one tenth of the volume of the acid precipitate volume.
This mixture was centrifuged (15 000 x g, 10 min, 4°C) and filtered through Whatman No. 4
filter paper to remove any undissolved material. The sample was loaded onto a pepstatin-
diaminohexane-Sepharose column (1.5 x 0.5 cm = 0.88 ml), that had been previously
equilibrated with loading buffer, at 5 cm h"1. The unbound eluate was recirculated through
the column overnight to ensure complete binding of cathepsin D to any available pepstatin
sites. The column was washed with a further 2 volumes of loading buffer and cathepsin D
eluted with elution buffer. Purity of the fractions was determined by SDS-PAGE (Section
2.4) and silver staining (Section 2.5), and the fractions pooled accordingly.
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3.3.3.3 Results and Discussion
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Figure 11. The elution of cathepsin D from pepstatin-Sepharose.
Pepstatin-Sepharose (Section 2.8) was equilibrated with loading buffer, and
bound cathepsin D was eluted with elution buffer, all at 5 cm h ' . The
elution buffer was applied at (-1).
As expected, cathepsin D was isolated in the single (45 kDa) and two-chain (30 kDa and
15 kDa) forms (Fig. 12). The yield of purified cathepsin D (Table 3) was significantly less
than that obtained by Jacobs et ai, (1989) . This is possibly due to the small size of the
pepstatin affinity column employed in this study.
1
kDa
68 •** w ; »
30 tHwm ^m^
20.1 4
14.4 " WjsJ i :
Figure 12. Tris-tricine SDS-PAGE of cathepsin D isolated from bovine liver.
The pepstatin-Sepharose fraction (lane 2) was boiled in reducing treatment
buffer and loaded onto a 10% tricine gel with MW markers (lane 1) (BSA
68 kDa; ovalbumin, 45 kDa; carbonic anhydrase, 30 kDa; trypsin inhibitor,
20.1 kDa; lysozyme, 14 kDa).
In order to complete the experiments described in Chapter 4 electrophoretically pure
cathepsin B and cathepsin D were needed. An achievement of the studies described in this
chapter, is that both enzymes could be isolated relatively rapidly and cost-effectively. The
modifications introduced in the protocol described by Meinesz (1996) resulted in an improved
yield of 4.46% when compared to the 0.05% yield of the original procedure. Significantly,
the modifications introduced into the procedure involved changes that did not affect the cost
or time-effectiveness of the original procedure. Cathepsin D was successfully isolated using
an established procedure (Fortgens, 1996) although the yields obtained were lower. The
amount of enzyme harvested from the purification was, however, sufficient for the studies
undertaken in Chapter 4.
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CHAPTER 4
THE REDUCTIVE ACTIVATION OF CATHEPSIN B
4.1 Introduction
Mammalian organisms have evolved a multi-tiered response to low oxygen levels, or hypoxia
(Fig. 13). At the cellular level hypoxia induces a dramatic response in cells because aerobic
metabolism is effectively inhibited. Cells switch over from oxidative phosphorylation to
glycolysis as a means of generating ATP. Specific glycolytic isoenzymes like lactate
dehydrogenase (LDH)-A, phosphofructokinase (PFK)-L, PFK-C, aldolase (ALD)-A,
ALD-C, and the glucose transporters GLUT-1 and GLUT-2, are upregulated under
conditions of low oxygen tension (Ebert et al., 1996).
Oxygen tension is sensed by a haem-dependent NAD(P)H-oxidase, which under normal
conditions binds free oxygen and converts it into hydrogen peroxide. The hydrogen peroxide
is converted into hydroxyl and hydroxide radicals via the iron-mediated Fenton reaction.
These reactive oxygen species (ROS) act as chemical messengers that suppress the
expression of genes induced by hypoxia. Low oxygen tension, or the presence of certain
transition metals (Co2+ and Ni2+) which compete for the metal binding site on the oxygen
sensor, disrupt the production of the ROS chemical messengers. This signal is relayed to the
transcription factor hypoxic inducible factor-1 (HIF-1) which mediates the increase in
transcription of the glycolytic enzymes described above. HIF-1 is a heterodimer that belongs
to the PAS family of transcription factors. Whilst HIF-la is a novel protein, HIF-ip had
been previously identified as the aryl hydrocarbon receptor nuclear translocator (ARNT).
HIF-1 regulation may be regulated by protein stability, phosphorylation, redox
modifications, or the retardation of complex formation with hsp90 (Huang et, al., 1997).
HIF-1 is also responsible for the induction of transcription of the vascular endothelial growth
factor (VEGF). VEGF stimulates the growth of blood vessels toward hypoxic tissue,
decreasing the diffusion distance for oxygen entry into hypoxic cells.
At a systemic level, mammals respond to hypoxia by hyperventilation which increases arterial
oxygen tension. This response is mediated by Type-1 cells of the carotid body. Low oxygen
levels trigger the release of dopamine, whose production is upregulated in these cells. The
rate limiting enzyme in dopamine biosynthesis is tyrosine hydroxylase, whose transcriptional
upregulation is simulated by HIF-1 and the c-Fos-JunB AP-1 heterodimer (Norris and
Millhorn, 1995).
A further systemic reaction to hypoxia is the transcriptional upregulation of the erythropoietin
(Epo) gene. Epo is a 30.4 kDa glycoprotein hormone produced in the kidney and liver and is
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upregulated between 50-100 times in response to hypoxia. Epo enters the plasma and binds
to specific receptors on erythroid progenitor cells and precursor cells. These cells are
stimulated to proliferate and differentiate into erythrocytes, increasing erythrocyte mass in the











Figure 13. Cellular, local and systemic responses to hypoxia are mediated by
HIF-1.
At a cellular level hypoxia activates HIF-1, which induces an increase in the
transcription of specific glycolytic enzymes. HIF-1 activation also triggers
the production of VEGF which stimulates the growth of blood vessels
toward hypoxic regions. At a systemic level HIF-1 activation increases the
delivery of oxygen to tissues by upregulating erythropoietin (Epo) and
tyrosine hydroxylase (TH) production. The effects of these factors are
discussed in the text.
Thus mammals have developed a hierarchy of systems to ensure that cells receive oxygen.
Most oxygen delivered to cells is tetravalently reduced, by oxidative phosphorylation, to
water. However, oxygen can also accept single electron transfers to produce the superoxide
radical (-CV). Reduction of -O2" by superoxide dismutase (SOD) produces H2O2, which in
turn is a substrate for catalases and peroxidases. H,O2 can combine with -O2" to produce the
hydroxyl radical (-OH), The hydroxyl radical is an extremely destructive species and can
react with virtually any molecule within the cell. The -OH radical and other radical species
can inactivate enzymes, break DNA, and initiate chain reactions that peroxidize lipids. Thus
oxygen in high concentrations is toxic, with its toxicity being mediated through the
production of ROS (Allen, 1991).
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Despite their toxicity and danger to molecules in a cell, ROS are used as chemical messengers
for oxygen sensing, and play a role in tissue differentiation. It has been shown that as cells
become more differentiated, a process associated with a loss of mitotic activity, they become
more oxidising. In contrast, tumour cells and cells with a high regenerative capacity like liver
cells, maintain a more highly reducing cytosolic environment (Allen, 1991).
Thus, the maintenance of oxygen homeostasis has profound effects on metabolism and cell
survival. Oxygen is necessary for oxidative phosphorylation where energy gains are greater
than in glycolysis. ROS which are generated by the reduction of oxygen serve as important
chemical messengers for oxygen homeostasis and differentiation. However, these ROS have
the capacity to damage a large number of cellular components, and possibly kill cells. In
order to protect against ROS, cells have developed several enzymatic and non-enzymatic
mechanisms to counter their deleterious effects. The susceptibility of the enzymatic
mechanisms to inactivation, suggests that non-protein oxidants are essential for dealing with
ROS (Allen, 1991).
In lipids a-tocopherol and p-carotene are responsible for limiting lipid peroxidation by
terminating chain reactions in membrane lipids. Hydrophilic antioxidants like GSH and
ascorbate remove ROS species from the cytoplasm by reacting directly with them. Reduced
glutathione (L-y-glutamyl-L-cysteinylglycine), or GSH, is widely distributed throughout
nature and is present in cells at a relatively high concentration, between 0.1-10 mM (Meister,
1995). Apart from being an antioxidant, GSH is the principal redox buffer within the
cytoplasm and is responsible for maintaining a reducing cytosolic environment. Maintaining
this redox environment is important for cellular polarity, compartmentalisation of ionic
charges within the cell, and for protein function and charge (Allen, 1991). Further, GSH
also functions as a storage and transport form of cysteine (Meister, 1995).
ROS and disulfides are reduced by GSH, which becomes oxidised to its disulfide form,
GSSG. GSSG reductase, which utilises NADPH as a co-factor, reduces GSSG back to
GSH. The enzyme GSSG-reductase catalyses an equilibrium that greatly favours the
formation of GSH, which is therefore present at concentrations 100-400 times that of GSSG
(Gilbert, 1995). NADPH, the co-factor for GSSG-reductase, is generated by oxidative
phosphorylation, and ultimately provides the reducing power within the cell. Thus, the
reducing power within a cell paradoxically depends on the delivery of oxygen to that cell
(Meister, 1995).
This relationship between cellular redox status and its dependence on oxidative
phosphorylation has received attention because of its application in ischaemia and secondary
metastatic dissemination. Solid tumours often have microenvironments that are hypoxic,
deprived of nutrients and of low pH. These environments select for apoptotically resistant
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and aggressive phenotypes (Graeber et al., 1996). Because these microenvironments do not
receive an adequate oxygen supply, they (paradoxically) are subjected to oxidative stress, and
tend to upregulate GSH production. GSH can detoxify many chemotherapeutic drugs (Cook
and Mitchell, 1995). Thus the combination of the tumour microenvironment and
chemotherapeutic drugs selects for those tumour cells that are extremely aggressive, and
resistant to chemical therapy.
1-3 GSH <-> 1 GSSG
Plasma
membrane
ATP + CO, + NADPH
I
100 GSH <-» 1 GSSG
Figure 14. The redox environments within the cell.
The highly reducing environment within the cytoplasm is generated by GSH. The
GSH:GSSG ratio is maintained by GSSG reductase which uses NADPH as co-factor.
NADPH is produced by glycolysis and the Kreb's cycle, and thus all the cellular redox
environments are modulated by oxygen delivery to the cell. The endosomal system has
pumps that transport cysteine into the system to generate what is believed to be a
reducing environment. The ER redox environment is kept relatively oxidising by
GSSG transporters. This redox environment together with molecular chaperonins
allows proteins to fold into their correct conformations. The mitochondrial (M) redox
system uses non-thiol redox systems and was not examined during this study.
The ER possesses a GSH:GSSG redox system (Fig. 14). In contrast to the cytoplasmic
redox environment, the redox environment within the ER is relatively oxidising. The ER
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redox environment is maintained at a GSH:GSSG ratio of 1-3:1. This ratio has been shown
to be optimal for protein folding, and for oxidoreductases like protein disulfide isomerase
(PDI). This relatively oxidising redox equilibrium within the ER is maintained by GSSG and
cystine transporters that transport the disulfides into the ER at a rate 10 times faster than for
GSH and cysteine respectively (Hwang et al, 1992).
The relatively oxidising environment of the ER thus favours protein disulfide formation. The
chemistry of disulfide formation involves the transfer of 2 electrons from a thiol to an
acceptor, resulting in the formation of a mixed disulfide. This bond is then attacked by a
cysteine residue, resulting in the formation of an intrachain disulfide bond. The ER redox
potential, as well as the microenvironment surrounding the cysteine residues, has
thermodynamic and kinetic effects on the formation and interchange of the disulfide (Huppa
and Ploegh, 1998). To ensure that the redox potential within the ER favours disulfide
formation, it appears that the ER has proteins dedicated to maintaining the lumenal redox
potential. Erolp is a membrane associated glycoprotein that is ubquitously expressed in
eukaryotic cells. Erolp is probably part of a redox cascade responsible for maintaining an
oxidising ER redox potential (Frand and Kaiser, 1998; Pollard et al., 1998).
As described above, the ER maintains a relatively oxidising environment to facilitate the
correct folding of a nascent polypeptide. The folding apparatus within the ER also includes
chaperonins like Bip/Kar2p which functions like a molecular ratchet in importing proteins
into the ER. Calnexin and calreticulin are Ca2+ dependent chaperones that bind unfolded
substrate in a lectin-type fashion. Oxidoreductases like PDI, and isomerases like protein
prolyl isomerase (PPI) also ensure that a nascent polypeptide assumes its stable and correct
conformation (Huppa and Ploegh, 1998). Thus, the refolding apparatus within the ER
appears to be very sophisticated and depends on both the redox environment and ER-resident
enzymes to ensure that a polypeptide folds into its correct conformation.
The endosome-lysosome system on the other hand, serves to reverse this process. The redox
environment within the late endosome-lysosome system must therefore favour the breaking
of disulfide bridges, and support the (mainly cysteine) endoproteases involved in degrading
endosomal substrates. In order to fulfil these requirements, the redox environment within the
late endosome-lysosome system is expected to be considerably more reducing than that of the
ER. Pisoni et al. (1990) have described a transporter which transports cysteine into the
"lysosome". This transporter is believed to be responsible for maintaining a reducing
endosomal environment. Lloyd (1992) has suggested that the stoichiometry of disulfide
exchange would not necessitate a lysosomal transporter. He asserts that the cysteine
transporter described by Pisoni etal. (1990), may constitute merely an anapleurotic pathway
that replenishes cysteine lost by auto-oxidation However, if disulfide bond formation and
thiol interchange are modulated by the redox environment (Huppa and Ploegh, 1998), a more
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reducing environment would favour the breaking of disulfides and concomitant formation of
thiols. This could be explained by the Nernst equation:
23RT, [oxidised form]
E=E0 + ^—\og—-—— -
rrt [reduced form]
where E is the reduction potential, Eo is the standard reduction potential at pH 7.0, 25°C and
at a gas pressure of 1 atm, [oxidised form] refers to the concentration of oxidising agent and
[reduced form] refers to the concentration of reducing agent. As the concentration of
reducing agent increases relative to oxidising agent, the environment would be expected to
become more reducing, favouring disulfide breakage.
A point that is often overlooked about redox potentials is their dependence on pH. Under
standard conditions (pH 7.00, 25°C, 1 atm), for every unit decrease in pH, the reduction
potential for a reaction becomes more oxidising by a factor of 0.059 V (Segal, 1976). The
following calculation highlights the effect that pH would have on the actual ratios of a redox
buffer under standard conditions. Within the ER, the GSH:GSSG ratio is maintained at 3:1
to ensure that disulfide bond formation is favoured. The standard reduction potential for such











This potential can be expressed in terms of the cysteine:cystine the 'lysosomal' redox buffer
(Pisoni and Thoene, 1991):
2MT [oxidised form]
E = Eo + — — log
- 0 , 2 4 4 . -Q.22
log
rft [reduced form]
t o s sed form]
[reduced form]
which gives a cysteine to cystine ratio of 7:1. This ratio would be expected to be higher than
the GSH:GSSG ratio because of the higher standard reduction potential of the cysteine:
cystine redox pair. By dropping the pH to pH 6.00, the standard reduction potential of the
system increases by a value of 0.059 V (Segal, 1976), to -0.161 V. Recalculation of the
cysteinexystine ratio needed to maintain the reduction potential of -0.244 V gives a cysteine:
cystine ratio of 651:1. Thus, changes in pH have profound effects on the redox potential
within a system.
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As described by Butor et al. (1995), the late endosomal pH may fluctuate from pH 4.5 to
alkaline pH values. These fluctuations could possibly induce pH dependent changes in the
redox potential. At a fixed concentration and ratio of cysteinercystine, the reductive potential
of a system would tend to be more oxidising at a lower pH than at a higher pH. This would
have an immediate effect on the ability of the system to reduce the disulfide bridges of a
substrate. This effect might, however, be offset by the denaturing changes induced in the
structure of the substrate by low pH. A further effect that these changes would have is on the
activation of cysteine proteases, which might be more readily activated at neutral rather than
acidic pH values.
In this chapter, exploration of the reductive activation of cathepsin B under various pH
conditions is reported. An attempt was made at determining the optimal redox potential for
cathepsin B in order to give some indication of the endosomal redox environment in which
the enzyme operates. It was found, for example, that the optimal in vitro GSH:GSSG ratio
for PDI (Lyles and Gilbert, 1991) approximated the GSH:GSSG ratio in the ER (Hwang
et al., 1992). Finally, the activation of the enzyme was compared to other proteases to
determine whether the observed reductive activation behaviour was unique to cathepsin B.
4 .2 Construction of redox buffer/activators
Thiol oxidation occurs extremely rapidly. It has been shown, for example, that the plasma
redox status changes markedly within 10-20 s of sampling (Mansoor et al., 1992). These
changes cannot be prevented by EDTA or antioxidants (Akerboom and Sies, 1981; Mansoor
etal., 1992). These observations are often not considered when describing the role of thiols
in supporting proteolysis (Kooistra etal., 1982; Collins et al., 1991). During this project
several methods were evaluated that allowed for the deoxygenation of solutions including
nitrogen sparging and photo-oxidation of anthroquinone sulfonate. The method chosen was
one that is used for the isolation of oxygen sensitive enzymes (Dr Thomas Urbig, pers.
comra.).
4.2.1 Reagents and Procedure
Reagents. Oxygen-free nitrogen was obtained from Afrox (South Africa). The reducing
agents cysteine, GSH, NADPH, dithiothreitol (DTT), and the disulfide cystine were obtained
from Sigma (St. Louis, MO) and were of the highest purity commercially available. All
buffers were constructed using Ultrapure Milli-Q water.
Acetate-MES-Tris (AMD buffers [100 mM acetate. 100 mM MES. 200 mM Tris. 4 mM
Na:EDTAl. Glacial acetic acid (1.43 ml), MES (4.88 g), Tris (6.06 g) and Na,EDTA
(0.375 g) were dissolved in 200 ml of dist.H2O. When needed, aliquots (20 ml) of solution
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were deoxygcnaled by boiling, cooled under oxygen-free nitrogen, and degassed under
vacuum. Reducing agent, or its oxidised counterpart, was added to these solutions at a
concentration to accommodate dilution during the assays employed. The pH of each solution
was titrated to values in the range 4-8.5 using HC1 or NaOH, and the buffers made up to
25 ml. All steps, including the pH and volume adjustments, were done under nitrogen.
4.3 Activation of cathepsin B by various reducing agents
Five reducing agents were tested for their ability to activate bovine cathepsin B: cysteine,
cystcamine, GSH, NADPH, and DTT (Fig. 15). Cysteine is believed to be the principal
reducing agent within the "lysosome" (Pisoni etai, 1990), and is also the predominant thiol
present within human plasma (Mansoor et ai, 1992). Cysteamine is the decarboxylated form
of cysteine and is recognised by the lysosomal cysteine transporter. Cysteamine is used in
the treatment of cystinosis. Cysteamine reacts with cystine to form cysteine and a mixed
disulfidc of cysteamine and cysteine that is transported out of the lysosome (Pisoni and
Thoene, 1991). GSH is the predominant cytosolic reducing agent, and NADPH is
responsible for generating the reducing power within the cell. DTT is a highly effective
reducing agent that is often used to activate cysteine proteinases in vitro. Oxidation of DTT
results in a stable cyclic disulfide product which draws the reaction to completion, making
DTT a very effective reducing agent. The thiol concentrations used in this assay ranged from
5-100 mM. At first glance these concentrations appear high, but it has been shown that













Figure 15. The structures of the thiol-reducing agents used to activate
cathepsin B.
(a) Cysteine; (b) DTT; (c) GSH, and (d) cysteamine.
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4.3.1 Reagents
Buffer/Activator F100 mM acetate. 100 mM MES. 200 mM Tris. 4 mM Na.EDTA. 0.02%
NaN:. 5-100 mM reducing agent. pH 6.01. The buffer/activator was made up as described in
Section 4.2.1 using the reducing agents cysteine, GSH, NADH, NADPH, DTT and
cysteamine.
1 mM CBz-R-R-AMC substrate stock solution. CBz-R-R-AMC (3.1 mg) was dissolved in
DMSO (5 ml), divided into 100 |il aliquots and stored at -4°C. When required, this stock
was diluted in dist.H2O to a working concentration of 40 uM .
1 mM CBz-F-R-AMC substrate stock solution. CBz-F-R-AMC (1 mg) was dissolved in
DMSO (1.5 ml), divided into 100 ul aliquots. When required, this stock was diluted in
dist.H20 to give a working concentration of 20 uM.
Diluent [0.1% Brijl. Brij (0.1 g) was dissolved in 95 ml of distilled water and made up to
100 ml.
4.3.2 Procedure
Enzyme sample (2.68 ug) was diluted to 125 ul with 0.1% Brij, and buffer/activator (750 ul)
added in. This sample was pre-incubated for 2 min at 37°C, and CBz-R-R-AMC or CBz-F-
R-AMC substrate solution was mixed in. The rate of change due to liberated AMC was
detenTiined continuously in a temperature-controlled Hitachi F-2000 spectrofluorometer with
excitation at 370 nm and emission at 460 nm.
4.3.3 Results and discussion
Despite having a lower standard reduction potential than cysteine (Segal, 1976), the tripeptide
GSH was not as effective at activating cathepsin B at low thiol concentrations (Fig. 16).
However, at a concentration of 100 mM, GSH proved to be the most effective reducing agent
tested. Bnmk et al. (1995) have demonstrated that leakage of lysosomal enzymes due to sub-
lethal oxidative stress might be a common event. The inability of GSH to effectively activate
cathepsin B at physiological concentrations (Meister, 1995) may offer the cell protection
against such lysosomal leakage.
A further indication that standard reduction potentials per se do not necessarily correspond to
the ability to activate cathepsin B, comes from the results of the activation of the enzyme by
NADPH. NADPH, which has one of the strongest reduction potentials within the cell
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Figure 16. The activation of cathepsin B activity by various reducing agents.
As described in Section 4.3.2, the ability of the reducing agents cysteine
(•), GSH (o), DTT (T), NADPH (V), and cysteamine (• ) to activate
cathepsin B was assessed by measuring the rate of CBz-R-R-AMC
hydrolysis. The rate of hydrolysis of the substrate CBz-F-R-AMC by
cathepsin B activated with cysieine was also determined ( • ) . The
activation conditions were generated using AMT redox buffers (Section
4.2.1) at pH 6.00 and at 37°C. The data represents the mean of 3
determinations.
Cysteamine, the decarboxylated form of cysteine, activated cathepsin B less than cysteine.
This was unexpected because of the structural similarities between these molecules. Further,
cysteamine activation of cathepsin B showed a steady increase in activation with increasing
concentration, with an optimal concentration at 20 mM cysteamine. DTT showed a normal
distribution of activity centred around 25 mM DTT. Cysteine activation of cathepsin B, on
the other hand, showed a dip in activity at 20 mM cysteine. This unusual pattern of activation
was noticed with different batches of enzyme and reducing agent. It was also noted in a
previous study (Meinesz, 1996) and hydrolysis of the CBz-F-R-AMC substrate showed a
pattern similar to that generated by the CBz-R-R-AMC substrate. Cysteine also proved to be
the most effective reducing agent tested, which is consistent with its role as reducing agent
within the endosomal system. The effectiveness of cysteine in activating cathepsin B, and its
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presence in plasma may have important implications on the enzyme's ability to act
extracellularly.
4.4 Determination of the number of cysteine binding sites on cathepsin B
The activation of cathepsin B by cysteine, indicates that the activation of the protease may not
be a simple titration of the active site thiol. A simple titration would be expected to show a
smooth curve of increasing activity with increasing cysteine concentration up to a maximum,
after which activity may decline due to reductive denaturation. Curves showing these
activation patterns were obtained for cysteamine and DTT, whilst GSH activation of
cathepsin B showed a progressive pattern of increasing activity with increasing GSH
concentration.
It was hypothesised that the titration pattern of cathepsin B by cysteine may indicate that
there is more than one ligand binding site for cysteine on the enzyme. Thus, cysteine may
facilitate inter- and intra-thiol exchanges in cathepsin B. Using a modified method (Tan.
1998) based on Wang-Srivastava plots (Wang and Srivastava, 1994), the number of ligand
binding sites for cysteine on cathepsin B was determined. This method graphically describes
the number of ligand binding sites by plotting the values l/v[L]n against the concentration of
cysteine [L], where v is the initial rate of the reaction , L is the concentration of cysteine, and
n = 0, 1, 2, 3... represents the number of putative ligand binding sites. The number of
ligand binding sites is indicated by the first plot showing a non-positive slope when
compared to the preceding and succeeding plots (Tan, 1998).
4.4.1 Reagents
Buffer/Activator flOO mM acetate. 100 mM MES. 200 mM Tris. 4 mM Na.EDTA. 0.02%
NaN,. 1-100 mM cysteine. pH 5.0-7.01. The buffer/activator was made up as described in
Section 4.2.1 using the reducing agent cysteine at concentrations between 1-100 mM
[0.00404 g-0.404 g/20 ml] to accommodate dilution in the assay.
1 mM CBz-R-R-AMC substrate stock solution. This solution was made up as described in
Section 4.3.1.
Diluent [0.1% Brijl. This solution was made up as described in Section 4.3.1.
Stop solution [100 mM monochloroacetate. 30 mM sodium acetate. 70 mM acetic acid.
pH 4.31. Monochloroacetate (9.45 g), Na-acetate (4.08 g) and glacial acetic acid (4 ml) were
dissolved in 950 ml of dist.H2O, titrated to pH 4.3 with NaOH and made up to 1 litre.
59
4.4.2 Procedure
Enzyme sample (2.68 ug) was diluted to 125 ul with 0.1% Brij, and 750 ul of
buffer/activator added in and the sample was pre-incubated for 2 min at 37°C. CBz-R-R-
AMC (125 ul) substrate solution was added in and the reaction was allowed to proceed for
10 min at 37°C. The reaction was terminated by the addition of stop solution (500 ul) and
the mixture was kept on ice. The fluorescence of the samples, due to liberated AMC, was
determined in a Hitachi F-2000 spectrofluorometer, with excitation at 370 nra and emission at
460 urn.
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Figure 17. Determination of the number of ligand binding sites for cysteine on
cathepsin B at pH 7.0.
The graphical analysis method of Tan (1998) was used to determine the
number of ligand binding sites for cysteine on cathepsin B. The first slope
showing a zero gradient at reasonably high cysteine concentrations is the
curve where n = 1, indicating that there is a single cysteine binding site on
cathepsin B. Each data point represents the mean of 3 determinations.
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Figure 18. Determination of the number of ligand binding sites for cysteine on
cathepsin B at pH 6.0.
The graphical analysis method of Tan (1998) was used to determine the
number of ligand binding sites for cysteine on cathepsin B. The first slope
showing a zero gradient at reasonably high cysteine concentrations is the
curve where n = 1, indicating that there is a single cysteine binding site on
cathepsin B. Each data point represents the mean of 3 determinations.
From the results in Figs. 17-19 , its appears that there is only a single ligand binding site for
cysteine on cathepsin B. This site is presumably the active site cysteine. Thus, the unusual
pattern of cathepsin B activation by cysteine cannot be due to multiple binding sites. The
pattern of activation is made all the more puzzling by the fact that the cysteine analogue
cysteamine, does not show a similar activation pattern, nor does the tripeptide GSH, which
uses a cysleinyl residue for thiol reactions. The unusual activation pattern of cathepsin B by









20 40 60 80
Concentration of cysteine, [L], (niM)
100 120
Figure 19. Determination of the number of ligand binding sites for cysteine on
cathepsin B at pH 5.0.
The graphical analysis method of Tan (1998) was used to determine the
number of ligand binding sites for cysteine on cathepsin B. The first slope
showing a zero gradient at a reasonably high cysteine concentration is the
curve where n = 1, indicating that there is a single cysteine binding site on
cathepsin B. Each data point represents the mean of 3 determinations.
4.5 Effect of pH on the reductive activation of cathepsin B.
The pH optimum and stability of cathepsin B has received much attention because of the
enzyme's role in extracellular pathological conditions like cancer and rheumatoid arthritis
(Yan et al., 1998). Of interest in the present study was the relationship between the pH
optimum of the enzyme and reducing conditions. This relationship may give some indication
of the activation conditions for the enzyme along the endocytic pathway. Several groups
have described a neutral to slightly alkaline pH optimum for cathepsin B against fluorometric
substrates (Willenbrock and Brocklehurst, 1985b; Khouri et al., 1991; Hasnain et al, 1992;
Moin et al., 1992; Dehrmann et al., 1996), whilst other groups have described acidic pH
optima for the enzyme (Barrett and Kirschke, 1981).
These differences may reflect the unique ability of cathepsin B to behave as both an
exopeptidase and an endopeptidase. Most lysosomal cysteine proteases tend to be
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endoproteolytic. The occluding loop, which is a unique structural feature on cathepsin B,
has two His residues that become protonated at pH 5.5. This allows the active site to dock
the carboxy terminus of a substrate, and therefore behave as an exopeptidase (Musil et al.,
1991; Illy et al., 1997). As described by Dehrmann et al. (1995) many reports describing pH
optima for thiol-dependent cathepsins have used anionic buffers of constant molarity over a
wide pH range. By doing this there is an increase in ionic strength with an increase in pH,
and this was shown to depress cathepsin L activity at higher pH's. This would also apply to
cathepsin B.
Dehrmann et al. (1996) have also described the increased stability of cathepsin B in
extracellular conditions upon reductive activation. This effect was possibly due to the ionic
interactions between the active site thiolate-imidazolium ion pair, that stabilises the structure
of the enzyme (Turk et al., 1994). Reductive activation of cathepsin B would be expected to
be more effective at higher pH's than lower pH for a given concentration of cysteine, if
activation depended solely on redox potential (Section 4.1). In this study the activity of the
enzyme was probed using thiol concentrations between 10-100 mM over a pH range 4-8.
4.5.1 Reagents
Buffer/Activator HOP mM acetate. 100 mM MES. 200 mM Tris. 4 mM Na^EDTA. 0.02%
NaNv 10-200 mM cysteine. pH 4.0-8.01. The buffer/activator was made up as described in
Section 4.2.1 between pH 4.0-8.0 using cysteine at concentrations between 10-200 mM
[0.0404 g-O.8O8 g/200 ml].
1 mM CBz-R-R-AMC substrate stock solution. This solution was made up as described in
Section 4.3.1.
4.5.2 Procedure
Cathepsin B (0.67 u.g) and redox buffer/activator (75 ul) was added to the wells of a white
Fluoronunc maxisorp microtitre plate and preincubated for 2 min at 37°C. Thereafter CBz-
R-R-AMC substrate (40 ul) was mixed in and the reaction allowed to proceed for 5 min at
37°C. The fluorescence of liberated AMC was determined semi-continously in a fluorescence
microplate reader (Cambridge Technology, Model 7620) with excitation at 370 nm and
emission at 460 nm.
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4 . 5 . 3 Results and discussion
As can be seen in Fig. 20, the pH optimum for bovine liver cathepsin B varies markedly with
changes in the cysteine concentration. The pH optimum of the enzyme appears to be
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Figure 20. The effect of pH and cysteine on cathepsin B activation.
AMT redox buffers (Section 4.2.1) were constructed with various
concentrations of cysteine (0-200 mM) and at various pH values (pH 4-8).
The activity of cathepsin B in these buffers was measured as described in
Section 4.5.2. The inset describes the relevant cysteine concentrations
used. The data represents the mean of 8 determinations.
concentrations. For example, in the presence of 25 mM cysteine, the optimal pH for
cathepsin B is pH 7, whilst at 100 mM cysleine, the pH optimum is between pH 5-6. These
results are consistent with the relationship between standard reduction potential and pH. As
conditions become more acidic, the standard reduction potential increases, requiring more
thiol to activate cathepsin B. These results suggest that there might be an optimal standard
reduction potential for cathepsin B. However these results must be viewed with caution as
the cathepsin B becomes oxidised during isolation. The in vivo redox status of the enzyme
has not been determined. An attempt was made at determining an optimal potential is
described in Section 4.6.
These results also suggest that it might be more thermodynamically favourable to activate
(oxidised) cathepsin B at a higher pH than at a lower pH for a given concentration of
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cysteine. For example if the intra-"lysosomal" cysteine concentration is 10 mM, at pH 7.0
cathepsin B would be more activated than at pH 4.0 (Fig. 20). Another argument in favour
of neutral pH activation of cathepsin B, and an alternate explanation of the phenomenon
observed in Fig. 20, is that the pKa of the cysteine thiol moiety is 8.3. Thus, at neutral pH a
larger portion of cysteine would be in the active thiolate form, favouring reduction when
compared to lower pH's. The activation of cathepsin B by a pH-dependent redox potential,
does provide a possible mechanism for regulating proteolysis. By acidifying an organelle, at
a fixed concentration of cysteine, the redox conditions within that organelle become relatively
oxidising. Thus, cysteine-protease dependent proteolysis could be shut-down by
acidification.
Whilst cathepsin B is activated very efficiently at neutral pH's, alkaline pH values (pH 8.0 in
this case) would tend to denature the enzyme (Fig. 20). Dehrmann et al. (1996) described a
pH optimum for human liver cathepsin B between pH 7-7.5. However, the half-life of the
enzyme at 37°C and pH 7.2 was 245 ± 11 s, but 857 ± 50 s at pH 6.8. Thus, whilst
cathepsin B shows a maximal activity at neutral to slightly basic pH values, it is more stable
at lower pH values. The activity of the enzyme must therefore be balanced between its
activation and destabilisation values. A scheme suggested by Mort and Buttle (1997) is that
cathepsin B could use its endopeptidase activity to cleave a substrate into smaller components
at neutral to slightly acidic pH values. As the pH decreases below 5.5, the enzyme's
exopeptidase activity would come into operation to hydrolyse these smaller components. The
activation of cathepsin B at higher pH is in keeping with this scheme.
4 .6 The effect of cystine on cathepsin B activation
The results in Section 4.5 suggested that cathepsin B might be optimally activated at a specific
reduction potential. The resistance of cathepsin B to non-thiol activation precluded the use of
cyclic voltametry to assess this reduction potential. Instead, a cysteine/cystine redox buffer
was used between pH 5-7. Cathepsin B activity was assessed against CBz-R-R-AMC, as
well as against haemoglobin. These results were compared against the action of the
lysosomal aspartic protease cathepsin D.
4.6.1 Reagents
Buffer/Activator A 1100 mM acetate. 100 mM MES. 200 mM Tris. 4 mM Na.EDTA. 0.02%
NaN,, 1-100 mM cysteine. pH 5.0-7.01. The buffer/activator was made up as described in
Section 4.4.1 using cysteine at concentrations between 1-100 mM.
Buffer/Activator B HOP mM acetate. 100 mM MES. 200 mM Tris. 4 mM Na:EDTA. 0.02%
NaN3. 1 mM cystine. 1-100 mM cysteine. pH 5.0-7.01. The AMT redox buffers were made
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up as described in Section 4.2.1 with the addition of 1 mM cystine (0.135 g/200 ml).
Cysteine at concentrations between 1-100 mM (Section 4.4.1) was added to 20 ml aliquots of
this buffer, the pH adjusted, and the buffer made up to 25 ml. These steps were all done
under nitrogen.
1 mM CBz-R-R-AMC substrate stock solution. This solution was made up as described in
Section 4.3.1.
Diluent [0.1% Brij]. This solution was made up as described in Section 4.4.1.
Stop solution [100 mM monochloroacetate. 30 mM sodium acetate. 70 mM acetic acid.
pH 4.31. This solution was made up as described in Section 4.4.1.
4.6.2 Procedure
Enzyme sample (2.68 ng) was diluted to 125 ul with 0.1% Brij, and either buffer/activator A
or buffer/activator B (750 ul) added in. This sample was pre-incubated for 2 min at 37°C.
Thereafter, CBz-R-R-AMC substrate solution (125 ul) was added in, and the reaction was
allowed to proceed for 10 min at 37°C. Reactions were terminated by the addition of stop
solution (500 ul) and the solutions kept on ice. The fluorescence of the samples, due to
liberated AMC, was determined in a Hitachi F-2000 spectrofluorometer, with excitation at
370 nm and emission at 460 nm.
4.6.3 Results and discussion
Cathepsin B did not show a requirement for a distinct reduction potential over all the pH
values tested. As can be seen in Fig. 21-23, cathepsin B was still maximally activated at pH
7.0 > pH 6.0 > pH 5.0 even in the presence of cystine. In Fig. 21, at pH 7.0, the 'cystine-
containing' curve follows the 'cysteine-only' curve until 10 mM cysteine. Thereafter, the
cystine curve does not vary as much as the cysteine-only curve. These results suggest that in
the presence of cystine, the activity of cathepsin B does not appear to vary with increases in
cysteine when compared to reactions with only cysteine. At pH 6.0, the cystine-containing
reactions were very similar to cysteine-only reactions (Fig. 22). As with the pH 7.0 cystine-
containing reactions, there did not appear to much variation of activity with changes in
cysteine concentration. The cystine-containing reactions at pH 5.0 appear to resemble the
cysteine-only reactions until 20 mM cysteine. Thereafter, the activity of the cysteine
containing reactions do not appear to vary with changes in cysteine concentration when
compared to the cysteine-only reactions.
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Figure 21. The effect of cystine on cathepsin B activation at pH 7.0.
In order to determine an optimal redox potential for cathepsin B, the
enzyme was activated in the presence of 1 mM cystine at various cysteine
concentrations, generating cystinexysteine redox buffers ranging from 1:1
to 1:100. The activation of cathepsin B in the presence of 1 mM cystine
(•) was compared to the activation of the enzyme without cystine (•) . The
data represents the mean ± s.d. (n=3).
Table 4 describes the results of an attempt to determine whether cystine modulates
cathepsin B activity such that it is relatively insensitive to changes in cysteine concentration.
If it is assumed that the data points for the individual cystine-containing reactions are
clustered around a straight line (which represents the modulated activation state of the
enzyme), then the standard errors of each line should be significantly smaller when compared
to the cysteine-only reactions. The standard errors associated with the cystine-containing
reactions are smaller than standard errors associated the cysteine-only reactions (Table 4).
Thus it appears that the presence of cystine may regulate cathepsin B activity such that it is
relatively insensitive to changes in cysteine concentration. The oxidising ability of cystine
could account for this insensitivity to changes in cysleine concentration. However, this effect
is not present at lower cysteine concentrations. Further, the effect would be expected to
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Figure 22. The effect of cystine on cathepsin B activation at pH 6.0.
In order to determine an optimal redox potential for cathepsin B; the
enzyme was activated in the presence of 1 mM cystine at various cysteine
concentrations, generating cystinexysteine redox buffers ranging from 1:1
to 1:100. The activation of cathepsin B in the presence of 1 mM cystine
(•) was compared to the activation of the enzyme without cystine (•) . The
data represents the mean ± s.d. (n=3).
Table 4. The ability of cystine to modulate cathepsin B activity.
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a The mean was calculated using all the data points for each reaction. For
example, the mean for the pH 7.00 (+cystine) reaction was calculated from the
velocities of all the reactions (1-100 mM cysteine, 1 mM cystine) undertaken at
pH 7.00 (Fig. 21). The standard error represents the average difference
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Figure 23. The effect of cystine on cathepsin B activation at pH 5.0.-
In order to determine an optimal redox potential for cathepsin B, the
enzyme was activated in the presence of 1 mM cystine at various cysteine
concentrations, generating cystinexysleine redox buffers ranging from 1:1
to 1:100. The activation of cathepsin B in the presence of 1 mM cystine
(•) was compared to the activation of the enzyme without cystine (•) . The
data represents the mean ± s.d. (n=3).
assumed that the modulation of cathepsin B activity is not solely due to the oxidising ability
of cystine per se. A possible explanation for this "modulating" effect could be that once
cathepsin B has been activated specific, or "threshold", redox potential, negative changes in
the redox potential no longer affect the activity of the enzyme. The redox potentials for the
cystine-containing buffers (Fig. 21-23) were calculated using the Nernst equation. The
purported threshold redox potentials for the reactions in Fig. 21-23 were estimated from the
graphs to be between -0.02 V to -0.12 V. These redox potential are significantly more
oxdising than the relatively oxidising redox environment found within the ER (Hwang et a I.,
1992). This would allow cathepsin B to operate under relatively oxidising conditions, and
was unexpected because the results obtained in Section 4.5 suggest that the enzyme may be
regulated by redox potential. The data in Section 4.5 may reflect the activation of an
artifactually oxidised enzyme. During isolation the active site thiol could be oxidised to
sulfinic acid, and the reduction of this moiety could be reponsible for the pH-thiol response
curves in Section 4.5. These results cast doubt on the hypothesised redox regulatory
mechanism described in Chapter 1. Thus, an alternate mechanism must exist for the
regulation of proteolysis along the endocytic pathway.
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4.7 The effect of varying concentrations of cystine on cathepsin B
activation.
In order to assess the results in Section 4.6, cathepsin B was activated in the presence of
varying concentrations of cystine. Cystine is poorly soluble above 1 mM and the
concentration range used varied from 0-1 mM cystine. All the reactions were carried out at a
cysteine concentration of 40 mM, which was the optimal cysteine concentration for the
activation of cathepsin B in the presence of 1 mM cystine at pH 6.0 and pH 7.0 (Fig. 21-22).
Activation of the enzyme was determined between pH 5-7, and the number of ligand binding
sites for cystine on cathepsin B was determined as described in Section 4.4.
4.7.1 Reagents
Buffer/Activator A F100 mM acetate. 100 mM MES. 200 mM Tris. 4 mM Na.EDTA, 0.02%
NaNv 0-1 mM cystine. 40 mM cysteine, pH 5.0-7.01. The buffer/activator was made up as
described in Section 4.2.1 and including cystine at concentrations between 0-1 mM.
Cysteine (0.162 g) was added to 20 ml aliquots of this buffer, the pH adjusted, and the
buffer made up to 25 ml. These steps were all done under nitrogen.
1 mM CBz-R-R-AMC substrate stock solution. This solution was made up as described in
Section 4.3.1.
Diluent [0.1% Brij]. This solution was made up as described in Section 4.3.1.
Stop solution riOO mM monochloroacetate. 30 mM sodium acetate. 70 mM acetic acid.
pH 4.31- This solution was made up as described in Section 4.4.1.
4.7.2 Procedure
Enzyme sample (2.68 ug) was diluted to 125 ul with 0.1% Brij, and either buffer/activator
(750 ul) added in. This sample was pre-incubated for 2 min at 37°C. Thereafter, CBz-R-R-
AMC substrate solution (125 ul) was added in, and the reaction was allowed to proceed for
10 min at 37°C. Reactions were terminated by the addition of stop solution (500 u.1) and the
solutions kept on ice. The fluorescence of the samples, due to liberated AMC, was
determined in a Hitachi F-2000 spectrofluorometer, with excitation at 370 nm and emission at
460 nm.
4.7.3 Results and discussion
The most prominent feature of cathepsin B activation, in the presence of varying
concentrations of cystine, is the lack of a distinct pattern that would allow cystine to be
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classified as an activator or as an inhibitor. This result would be consistent with the results
obtained in Section 4.5, which suggested thatcathepsin B has an optimal reduction potential.
Therefore, cysiine would be expected to behave as the oxidation half of a redox system, and
not as a classical inhibitor or activator. A further feature of the activation curves presented in
Fig. 24 is the variation of the data at pH 7.0>pH 6.0>pH 5.0. As described in Section 4 .1 ,
redox potential is a function of pH, and thiol interchange would be favoured at higher, rather
than lower, pH values. The increased variation noted at pH 7.0 when compared to the other
pH values is probably due to increased ihiol interchange at this pH. Similarly thiol
interchange would be more thermodynamically favoured at pH 6.0 compared to pH 5.0.
0.0 0.2 0.4 0.6 0.8
Cysiine concentration (mM)
1.0 1.2
Figure 24. The activation of calhepsin B in the presence of various
concentrations of cystine.
Calhepsin B was activated in AMT redox buffers containing varying
concentrations of cysiine and al 40 mM cysteine (Section 4.7.2). The
activation of the enzyme was compared at pH 5.00 (T), pH 6.00 (O) and
pH 7.00 (•) . The data represents the mean ± s.d. (n=3).
Al first glance, the pH 5.0 data in Fig. 24 seems to indicate that cystine has little or no effect
on calhepsin B activation, except for a slight drop in activation as conditions become more
oxidising (cysiine concentration increases). These results are inconsistent with the effect mat
1 mM cystine has on calhepsin B activation with varying cysteine concentrations (Fig. 23).
Here cystine, seemed to modulate enzyme activity around an apparently stable velocity. This
apparent inconsistency in the results shown in Fig. 23 and Fig. 24 could be explained by
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considering the actual ratios of cysteinexystine. At a concentration of 0.8 mM cystine, in the
presence of 40 mM cysteine, the thiol/disulfide ratio is 50:1 and the reaction proceeds at a
velocity of 218.93 ± 5.46 pmol. sec"1. From Fig. 24 which describes the activation of
cathepsin B in 50 mM cysteine and 1 mM cystine (50:1 thiol disulfide ratio), the activity of
the enzyme is very similar (221.41 ± 2.29 pmol. sec'1). The thiol/disulfide ratio given by
0.6 mM in the presence of 40 mM cystine is 67:1. The velocity of this reaction is very
similar to the velocity of the cysteine: cystine, 70:1 reaction in Fig. 23. The 0.4 mM cystine:
40 mM cysteine reaction (1/100) does not however correspond to the result in Fig. 23. These
results indicate that the activation of the enzyme depends on specific redox potentials, and any
pattern in the curves described in Fig. 24 is essentially meaningless. Each reaction has a
unique thiol-disulfide generated redox potential, and therefore a distinct velocity. Thus, a
distinct pattern of activation may not be apparent.
At pH 6.0, with varying cysteine concentrations, those reactions which included
1 mM cystine showed similar velocities to those reactions without cystine (Fig. 22). In this
case, it would have been expected that changes in the cystine concentration would not have
large effects on the activation of the enzyme. As the results in Fig. 24 describe, the changing
cystine concentration appears to cause large changes in the velocity of the reactions, but not
with a specific pattern. A similar fluctuating pattern is observed for the activation of
cathepsin B at pH 7.0 with varying concentration of cystine. Unlike the data for pH 5.0,
comparing the thiol:disulfide ratios from Fig. 21 and Fig. 22 with Fig. 24 does not give
corresponding velocities for enzyme activation at pH 6.0 and pH 7.0. These inconsistencies
are possibly due to the increased thiol-exchange and reducing conditions at these higher pH's
when compared to pH 5.0. For example, a cystinexysteine ratio of 1/100, in Fig. 21 for
example, is due to a ratio of 1 mM cystine: 100 mM cysteine. A 0.4 mM cystine:40 mM
cysteine ratio also gives a disulfide:thiol ratio of 1:100, and a similar redox potential, but the
conditions in this reaction would be considerably different. Its has been shown by Raman
et al. (1996) that the absolute concentrations of reactants in a thiohdisulfide reaction influence
the redox reactions of that system. In their experiment, a constant thiol:disulfide ratio of 10:1
was maintained for GSH:GSSG, cysteinexystine, and DTT:oxidised DTT, with varying
concentrations of each reagent. It was shown that the refolding of denatured/reduced
lysosome was influenced by the absolute concentrations of the reagents in the thiohdisulfide
redox buffer.
Apart from the absolute concentration of the redox reagents used, and the pH-mediated
changes in redox potential, a further factor that would influence the activity of the enzyme, is
the differing half-lives of the enzyme at different pH values. The individual contribution of
all these factors to enzyme activity is very difficult to quantify, and thus future experiments to
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determine the optimal redox potential of cathepsin B should perhaps focus on structural
changes associated with activity rather than activity perse.
The data obtained in Fig. 24 was used to determine the number of ligand binding sites for
cystine on cathepsin B. As the results in Fig. 25 indicate, cystine does not appear to have
any ligand binding sites on cathepsin B. Thus, the activity of the enzyme may be affected by
a general rcdox potential and not by a specific thiol-disulfide interchange at the active site for
example. It is therefore reasonable to expect that this potential would affect potential
substrates. In order to evaluate the effect that these redox systems would have on
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Figure 25. Determination of the number of cystine binding sites on cathepsin B
at pH 7.0.
Caihepsin B was activated by 40 mM cysteine in the presence of varying
concentrations of cystine. This data was used to generate plots to
determine the number of ligand binding sites for cystine on cathepsin B
using the method of Tan (1998). As the figure indicates, cystine does not
appear to have a specific ligand binding site on cathepsin B. Similar results
were obtained at pH 6.0 and pH 5.0 (data not shown).
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4.8 Effect of cysteine/cystine on the action of cathepsin B against
haemoglobin.
The effect of thiol and disulfide activation on cathepsin B activity was evaluated using an
assay based on an assay for cathepsin D. Enzyme sample was incubated with haemoglobin at
various concentrations of cysteine and/or cystine between pH 5-7. Hydrolysis of
haemoglobin generates TCA-soluble peptides which can be quantified by their absorbance at
A
4.8.1 Reagents
Buffer/Activator A HOP mM acetate. 100 mM MES. 200 mM Tris. 4 mM Na2EDTA. 0.02%
NaNL. 1-50 mM cysteine. pH 5.0-7.01. The buffer/activator was made up as described in
Section 4.6.1.
Buffer/Activator B flOO mM acetate. 100 mM MES. 200 mM Tris. 4 mM Na:EDTA. 0.02%
NaN3. 1-50 mM cysteine. 1 mM cystine. pH 5.0-7.01. The buffer/activator was made up as
described in Section 4.6.1.
5% (m/v) Haemoglobin substrate. Bovine haemoglobin powder (0.5 g) was dissolved in
dist.H,0 (10 ml) with magnetic stirring.
Diluent TO. 1% Briji. This solution was made up as described in Section 4.3.1.
TCA-stop solution \\0% (m/vVI. TCA (10 g) was made up to 100 ml with dist.H,O.
4.8.2 Procedure
Cathepsin B sample (6.7 ng) was diluted to 125 ul with 0.1% Brij, and either
buffer/activator A or buffer/activator B (750 ul) added in. This sample was pre-incubated for
2 min at 37°C. Thereafter, haemoglobin substrate solution (150 |J.l) was added in, and the
reaction was allowed to proceed for 10 min at 37°C. Reactions were terminated by the
addition of TCA-stop solution (500 ul) and kept on ice. The presence of TCA-soluble
degradation products was determined at A280 using a Pharmacia Ultraspec 2000
spectrophotometer. In control experiments, the enzyme sample was replaced by dist. H2O in
the reaction mix. The TCA-soluble supernatants of these reactions were used as blanks for
the corresponding reactions with active enzyme.
4.8.3 Results and discussion
The pattern of hydrolysis of haemoglobin by cathepsin B at various cysteine concentrations
(Fig. 26-28) is very different to the patterns observed in Fig. 21-23. Unlike cathepsin B
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hydrolysis of CBz-R-R-AMC, haemoglobin hydrolysis does not proceed optimally at pH 7.0
over all concentrations of cysteine. For example, at 20 mM cysteine, the hydrolysis of
haemoglobin proceeds optimally at pH 6.0>pH 5.0>pH 7.0. At this concentration of
cysteine hydrolysis of the CBz-R-R-AMC substrate proceeds optimally at pH 7.0
>pH 6.0>pH 5.0. The differences observed in the pH optimum could be due to the effect of
the haemoglobin substrate. The lower pH might promote acid-dependent denaturation of the
haemoglobin substrate, increasing the number of susceptible cleavage sites on the molecule.
An alternate explanation is that these results are artifacts generated by the experimental
procedure employed. The degree of haemoglobin hydrolysis is assessed by TCA-soluble
peptides. At lower pH's (< pH 5.5), cathepsin B behaves as an exopeptidase (Illy et al.,
1997), an activity which is more likely to generate TCA-soluble products, than the
endopeptidase activity of the enzyme. Thus, the results obtained at higher pH's (pH 7.0)
may be an underestimate of the extent of haemoglobin hydrolysis. One other factor could
contribute to the differences observed in hydrolysis of the whole protein when compared to
the fluorometric substrate. The hydrolysis of a whole protein by lysosomal proteases is a
synergistic process between the enzymes and the reducing effect of a thiol (Kooistra et al.,
1982). These factors might work optimally together at specific conditions of pH vs thiol
concentration vs enzyme activity. This could explain the variability of the responses to
changing thiol concentration (Fig. 26-28).
The most striking aspect of the data presented in Fig. 26-28, is the stimulating effect of
cystine on the proteolysis of haemoglobin, an effect not seen with the fluorometric assay.
This stimulatory effect could be directed at either cathepsin B or against the haemoglobin
substrate. It is unlikely that cathepsin B activation by cystine is responsible for the increased
proteolysis seen in Fig. 26-28. Firstly, as the results in Section 4.7 describe, there are no
ligand binding sites for cystine on cathepsin B and so it is difficult to imagine how the
disulfide might stimulate proteolysis. Also, this stimulatory effect is not observed for
cathepsin B hydrolysis of CBz-R-R-AMC. This suggests that cystine has an effect on the
haemoglobin substrate. Cystine might therefore be more than just a by-product of lysosomal
hydrolysis.
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Figure 26. The effect of cystine on the hydrolysis of haemoglobin by
cathepsin B at pH 7.0.
In order to determine the effect of cystine on cathepsin B activity against a
whole protein substrate, cathepsin B was activated in the presence of 1 mM
cystine a various cysteine concentrations (1-50 mM) (•). These reactions
were compared to the activity of cathepsin B without cystine (•) . The
assay is described in Section 4.8.2. The data represents the mean ± s.d.
(n=3).
Cystine could stimulate hydrolysis of haemoglobin by increased denaturation of the
haemoglobin substrate. However, the activities of cathepsin B described in Fig. 26-28 were
relative to controls that included cystine (Section 4.8.2), suggesting that this is not the case.
Further, tliere is no evidence in the literature for this denaturing type of activity. On the
contrary, it appears that cystine tends to promote the correct folding of substrates. Raman
et al. (1996) found that cystine alone (in the absence of cysteine) was able to stimulate the
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Figure 27. The effect of cystine on the hydrolysis of haemoglobin by
cathcpsin B at pH 6.0.
In order to determine the effect of cystine on cathepsin B activity against a
whole protein substrate, cathepsin B was activated in the presence of 1 mM
cystine a various cysteine concentrations (1-50 mM) (•) . These reactions
were compared to the activity of cathepsin B without cystine (•) . The
assay is described in Section 4.8.2. The data represents the mean ± s.d.
(n=3).
How would this explain the increased proleolysis observed in Fig. 26-28? Consider the
hydrolysis of haemoglobin: during this process, the hydrophobic core regions that are
normally shielded from the aqueous environment presumably become exposed. These
exposed hydrophobic regions could bind to other hydrophobic patches, resulting in
aggregation. This insoluble aggregate would be unavailable for hydrolysis, effectively
decreasing the substrate concentration. The oxidising ability of cystine to promote protein
structure, might decrease the hydrophobic interactions between substrate molecules being
degraded. This would increase the available substrate in the system. Support for this
interperation of the results above comes from the fact that the reaction velocites of the
cysteinc-only curves were significantly smaller than those undertaken in the presence of
cystine as well. Further, all the reactions described in Fig. 26-28 were undertaken relative to
control reactions without enzyme (Section 4.8.2) suggesting that the stimulation of
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proteolysis observed with cystine was a synergystic process between disulfide and
cathepsin B. This would give wieght to the suggestion that cystine may increase the
available substrate within the system. That the stimulatory effect observed in Fig. 26-28 may
be due to the oxidative properties of cystine, is evident by the way that the velocities of the
cysteine-only, and the cystine-containing reactions approach each other with increasing
concentrations of cysteine. As the concentration of cysteine increases, the conditions within
the system become more reducing, abrogating the effect of cystine.
Most studies on the relationship between lysosomal enzymes and thiols have assumed that the
lysosomal milieu is reducing. This would activate lysosomal enzymes, and stimulate the
degradation of the substrate by loosening its conformation. Cystine has been assumed to be a
degradation by-product that is exported out of the lysosome by a cystine-specific transporter
(Pisoni and Thoene, 1991). The experimental results reported here suggests that cystine
stimulates proteolysis of substrate, and might be a functional component of a redox buffer
system. This system could prevent aggregation of partially degraded substrate, thereby
increasing the substrate available for hydrolysis. This redox system may be functionally
similar to the ER GSH:GSSG system. The ER redox system (together with chaperonins)
serves to promote the folding of nascent polypeptides, preventing aggregation through
hydrophobic interactions (Johnson and Craig, 1997). The endosomal system on the other
hand, serves to undo this process, and it is not surprising that, in the complex milieu of the
endosomal system, the aggregation of substrate through inappropriate hydrophobic
interactions could be an important factor during hydrolysis. It should be noted however that
the experimental data presented here does not give a definate mechanism on how cystine
might work in stimulating proteolysis. Unlike lysozyme, haemoglobin does not use disulfide
bonds to maintain its structure and more work needs to be done to determine the mechanism
through which cystine exerts its effects.
Support for this concept comes from the work of Cuervo and Dice (1998). These authors
have found that a constitutively expressed heat shock protein, hsc 73, is selectively
internalised into the endosomal system from the cytosol. Hsc 73 appears to bind to a specific
cytoplasmic tail sequence of LAMP-2, an integral lysosomal membrane protein, and is
internalised through a pore on the lysosomal membrane. Thus the lysosomal-endosomal
matrix has 2 components to prevent protein aggregation. The envisioned degradation of a
protein within the endosomal system might involve multiple steps of degradation, and
shielding of hydrophobic groups by either chaperonins or redox-buffer mediated folding.
These steps would ensure that no substrate is lost through aggregation
The redox system within the late-endosomal/lysosomal system is presumably more reducing
than the ER redox system. The cysteinexystine system must promote substrate denaturation,
but prevent aggregation. This system appears to be well suited to the endosomal system.
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Figure 28. The effect of cystine on the hydrolysis of haemoglobin by
cathepsin B at pH 5.0.
In order to determine the effect of cystine on cathepsin B activity against a
whole protein substrate, cathepsin B was activated in the presence of 1 mM
cystine a various cysteine concentrations (1-100 mM) (•). These reactions
were compared to the activity of cathepsin B without cystine (•) . The
assay is described in Section 4.8.2. The data represents the mean ± s.d.
(n=3).
Cysteine is a highly effective activator of lysosomal cathepsin B when compared to GSH for
example (Section 4.3). Also, the cysteine:cystine redox pair would not be susceptible to
hydrolysis by lysosomal proteases as would a tripeptide like GSH. Despite their similar
potentials, the cysteine:cystine system also has a greater capacity for folding relatively high
concentrations of substrate when compared to the GSH:GSSG system (Raman etal., 1996).
An argument against such a system would be that the rate of proteolysis is sufficiently rapid
to prevent the hydrophobic interactions responsible for aggregation. It has been shown that
protein turnover within the 'lysosome' occurs with a half-life of approximately 8 min. This
rapid rate is probably due to the high concentration of proteases within the system, which can
approach 1 mM for certain enzymes (Bohley and Seglen, 1992). However, aggregation of
substrate can occur very rapidly. For example, denatured/reduced hen lysozyme, at
concentrations from 148 ug/ml to 18.5 ug/ml, aggregates completely in less than 1 minute
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(Goldberg etal., 1991). An appropriate redox system, and chaperonins if necessary, might
nrpvent snrh noorp.ontinnp e t uc  agg egatio .
4.9 Cathepsin D hydrolysis of haemoglobin in the presence of
cysteine/cystine redox buffers.
In order to determine whether cystine exerts a general effect on lysosomal proteolysis, its
effect on the hydrolysis of haemoglobin by cathepsin D was assessed. If the conclusions
described in Section 4.8 are accurate, cystine would be expected to promote proteolysis by
cathepsin D. Such a result would give further weight to the suggestion that cystine exerts its
effect on the substrate rather than on the cathepsin B enzyme.
4.9.1 Reagents
Assay buffer A [250 mM sodium citrate. 0.02% NaN3. 0-50 mM cysteine, pH 3.21. Citric
acid (26.3 g) and NaN3 (0.1 g) were dissolved in about 450 ml of dist.H2O, adjusted to
pH 3.2 with NaOH and made up to 500 ml. Cysteine (0-0.202 g) was added to aliquots
(20 ml) of this buffer to give a final concentrations after dilution of between 0-50 mM. After
the addition of cysteine, the pH was checked and the solution made up to 25 ml. All steps
were carried out under nitrogen.
Assay buffer B [250 mM sodium citrate. 0.02% NaN3. 1 mM cystine. 0-50 mM cysteine
pH 3.21. Citric acid (26.3 g), NaN3 (0.1 g), and cystine (0.3375 g) were dissolved in about
450 ml of dist.H2O, adjusted to pH 3.2 with NaOH and made up to 500 ml.. Cysteine (0-
0.202 g) was added to aliquots (20 ml) of this buffer to give final concentrations (after
dilution during the assay) between 0-50 mM. After the addition of cysteine, the pH was
checked and the solution made up to 25 ml. All steps were carried out under nitrogen
5% (m/v) Haemoglobin substrate. Bovine haemoglobin powder (0.5 g) was dissolved in
dist.H2O (10 ml) with magnetic stirring.
5%' (m/v) Trichloroacetic acid. Trichloroacetic acid (5 g) was dissolved in dist.H2O and
made up to 100 ml.
4.9.2 Procedure
Cathepsin D sample (6.7 ug) was diluted to 125 |il with 0.1% Brij, and either assay buffer A
or assay buffer B (750 ul) added in. Samples were pre-incubated for 2 min at 37°C.
Thereafter, haemoglobin substrate solution (150 |il) was added in, and the reaction allowed to
proceed for 10 min at 37°C. Reactions were terminated by the addition of TCA-stop solution
(500 ul) and kept on ice. The presence of TCA-soluble degradation products was determined
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at AM0 using a Pharmacia Ultraspec 2000 spectrophotomcter. In control experiments, the
enzyme sample was replaced by dist. H2O in the reaction mix. The TCA-soluble
supernatanLs of these reactions were used as blanks for the corresponding reactions with
active enzyme.





Figure 29. The effect of cysteine and cystine on cathepsin D hydrolysis of
haemoglobin.
Cathepsin D was activated in the presence of cysteine (1-50 mM) (O).
These reactions were compared to reactions that included 1 mM cystine,
also in the presence of cysteine (1-50 mM) (•). The assay was undertaken
at pH 3.2 and is described in Section 4.9.2.
Cystine seems to promote proteolysis of haemoglobin by cathepsin D at all concentrations of
cysteine tested (Fig. 29). Thus, the effect of the disulfide is not limited to cysteine proteinase
mediated hydrolysis. Cystine stimulation of haemoglobin proteolysis occurs synergystically
with cathepsin D (see "control reactions", Section 4.9.2). The curves in Fig. 29 show a
similar response to changes in cysteine concentration, and approach each other as the cysteine
concentration increases. This pattern, similar to that observed in Section 4.8, suggests that
stimulation of proteolysis is due to the oxidative properties of cystine. In fact, maximal
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activation of proteolysis occurs in the absence of cysteine and at a cystine concenti'ation of
1 mM. Both curves show a local minimum at 10 mM cysteine. The repression of
cathepsin D activity at 10 mM cysteine has been reported previously, although no
explanation for this effect has been offered (Ikeda et al., 1990).
Both the cysteine-only and the cystine-containing reactions show enhanced proteolysis at
cysteine concentrations above 10 mM. Because this effect is observed in both curves, it
probably represents the denaturation of the haemoglobin molecule. These results would be
consistent with those reported by Kooistra etal. (1982) and Mego (1984).
4.10 The effect of cysteine on the action of papain and trypsin.
The rate-limiting steps in the hydrolysis of a protein substrate, along the endocytic pathway,
are probably carried out by endoproteases (Bohley and Seglen, 1992). Endoproteases would
generate polypeptide fragments that can then be hydrolysed more effectively by the lysosomal
exopeptidase pool. The majority of lysosomal endoproteases are cysteine proteases, with
four exceptions. Cathepsins D and E are aspartic proteases with acidic pH optima. Their role
is presumably to process substrate under low pH conditions, where the cysteine proteases
might be inefficiently activated (Section 4.5). The endosomal system also has 2 serine
endoproteases, cathepsin G and prolyl endopeptidase (Bohley and Seglan, 1992). Cathepsin
G expression is confined to haematopoietic cells, but prolyl endopeptidase is more widely
expressed. Serine proteases are widely distributed and expressed in mammalian tissues
(Barrett and McDonald, 1980). These proteases usually have neutral to slightly alkaline pH
optima and, unlike cysteine proteases, do not require reducing conditions for activation.
Despite their wide expression, pH optima and activation conditions, serine endoproteases
have not been selected for in the endosomal-lysosomal system. Cysteine proteases, which
are not as commonly expressed in mammalian tissues, appear to fill the role of










Figure 30. Scheme of the mechanism of action of serine (A) and cysteine (B)
proteases.
X stands for OR' or NHR' group in acylation and for OH group in
deacylation (Polgar el al., 1986).
An important reason why cysteine proteases would be used in preference to serine proteases,
is that they tend to be more efficient catalysts. The difference in their catalytic efficiency is
based on the mechanism of proteolysis by the active site residues (Fig. 30). Serine protease
mediated cleavage of a substrate involves general base-catalysed acylation, resulting in the
formation of a tetrahedral intermediate (THI). The THI undergoes general acid catalysed
decomposition and, in a symmetrical process, deacylation. The first step in deacylation is the
general base catalysed formation of a second THI, and this is followed by general acid based
decomposition of this THI. Cysteine protease catalysis also involves acylation and
deacylation steps, but these steps involve simple nucleophilic attack by the active site
cysteine. Thus, proteolysis by cysteine proteases tends to be simpler and more efficient
(Polgar etai, 1986).
There are iwo further mechanistic differences between the action of serine and cysteine
proteases. Firstly cysteine proteases, which have a thiolate-imidazolium active site, lack the
catalytic triad present on serine proteases (serine, histidine and aspartic acid). The aspartate is
responsible for charge stabilisation of the negative THI and positive imidazolium ion
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generated during catalysis. Charge stabilisation of this nature does not play a role in the
cysteine protease hydrolytic mechanism. A further difference between the two classes of
protease, is that it is critical for serine proteases to stabilise the oxyanion of the THI (by
hydrogen bonding); a requirement not essential for cysteine protease hydrolysis (Polgar
etai, 1986).
The dependence of serine proteases on the catalytic triad, and on oxyanion stabilisation, is
due to the energy required to activate serine proteases from their ground state to the active
transition state, i.e. from the neutral to ion-pair form of the enzyme. Cysteine proteases do
not require this investment of energy as the thiolate imidazolium ion pair is already 'activated'
and there is no need for charge separation. Another mechanistic difference between these two
classes of protease is that the thiolate has a more acidic pKa than the hydroxyl group and this
favours the formation of the thiolate-imidazolium ion pair. This ion pair makes the thiol
group an extremely good nucleophile for acylation, and also a good leaving group in
deacylation. These factors together ensure that transitional state stabilisation, which
determines the thermodynamic and kinetic parameters of catalysis, is realised in a simpler
way in cysteine than in serine proteases (Polgar et ai, 1986).
The thiolate-imidazolium ion pair has another advantage that would favour the use of cysteine
proteases in the endosomal/lysosomal system. Cysteine proteases have a broad pH-activity
profile that is due to the existence of 2 ionisation pathways for the active site residues.
Consider the acidic limb in Fig. 31: as the pH decreases the thiolate group would become
protonated at its pKa which is approximately pH 4 in papain. This low pKa is due to the
microenvironment surrounding the thiolate. In order for the enzyme to be completely
inactivated (neutral form), the pH has to increase to cause ionisation of the imidazole proton.
However, increasing the pH would favour the formation of the ion pair. A similar argument








Figure 31. The change in the ion state of the active site residues of cysteine
proteases with changes in pH.
Ttie broad substrate specificity of cysteine proteases is due to the stability
of the active site thiolate-imidazolium ion pair. Structural features ensure
that the ionic forms of the active site residue are favoured over the neutral
form. Further, the ion pair itself is resistant to pH-dependent inactivation.
For example, as the pH decreases, the active cysteine should become
protonated. In order for the enzyme to become the neutral form, the pH
must increase, favouring formation of the thiolate-imidazolium ion pair
(Storer and Menard, 1994).
This study has yielded results that suggest thai cysieine proteases within the endosomal
system might be regulated by pH-dependent changes in redox potential within the system
(Section 4.5). Thus, proteolysis could be regulated without the need for specific inhibitors.
The results obtained in preceding sections suggest one further property that distinguishes
cysteine proteases as being useful proteases within the endosomal system. Cathepsin B and
cathepsin L (Dchrmann et al., 1995) appeal" to be stable to high concentrations of reducing
agent which may be well in excess of the physiological thiol concentrations (Section 4.5). It
was decided to explore whether this is a unique property of cysteine proteases, such as
cathepsin B, by comparing the activation of trypsin, a serine protease, with another cysteine
protease, papain, with increasing concentrations of reducing agent.
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4.10.1 Reagents
Buffer/activator A HOP mM acetate. 100 mM MES. 200 mM Tris, 4 mM Na.EDTA. 0.02%
NaN3. 1-50 mM cysteine. pH 6.0-7.01. The buffer/activator, used to activate papain, was
made up as described in Section 4.6.1.
Buffer/activator B HOP mM acetate. 100 mM MES. 200 mM Tris. 4 mM Na:EDTA. 0.02%
NaN3. lmMcystine. 1-50 mM cysteine. pH 6.0-7.01. The buffer/activator, used to activate
papain, was made up as described in Section 4.6.1.
Trvpsin assay buffer [10 mM Tris-HCl. 1-50 mM cvsteine. pH 8.001. Tris (0.06lg) was
dissolved in dist.H2O (40 ml), titrated with HCl to pH 8.0 and made up to 50 ml. Cysteine
(0-0.202 g) was added to aliquots (20 ml) of this buffer to give final concentrations (after
dilution during the assay) of between 0-50 mM. After the addition of cysteine, the pH was
checked and the solution made up to 25 ml. All steps were carried out under nitrogen
Papain solution [0.2 mg/mli. Papain (0.2 mg) was dissolved in buffer/activator (1 ml,
Section 3.2.1.1) without the addition of DTT.
Trvpsin solution [0.2 mg/ml], Trypsin (0.2 mg) was dissolved in trypsin diluent (1 ml).
Trvpsin diluent \2 mM HC11. HCl [32% (v/v); p = 1.16 g.ml1] (19.6 ul) was dissolved in
dist.H,O(100ml).
1 mM CBz-R-AMC. CBz-R-AMC (0.9 mg) was dissolved in DMSO (1.5 ml), and stored at
4°C. This stock solution was diluted to a 20 uM working solution with dist.H2O when
required.
5% (m/v) Haemoglobin substrate. Bovine haemoglobin powder (0.5 g) was dissolved in
dist.H2O (10 ml) with magnetic stirring.
Diluent [0.1% Brij"|. This solution was made up as described in Section 4.3.1.
TCA-stop solution [10% (m/vYl. TCA (10 g) was made up to 100 ml with dist.H2O.
4.10.2 Procedure
For the synthetic substrate assays, the appropriate assay buffer (75 ul) was added to the
enzyme sample (12.5 ul) in a white Fluronunc maxisorp microtitre plate. This mixture was
incubated at 37°C for 2 min and thereafter substrate solution (25 ul) was added in. After
10 min at 37°C the fluorescence of the liberated 7-amino-4-methylcoumarin was determined
in a fluorescent microplate reader (Cambridge Technology, Model 7620) with excitation at
370 nra and emission at 460 nm. Enzyme activity was described as arbitrary fluorescence
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units. For the haemoglobin substrate assays, enzyme (100 ul) and the appropriate assay
buffer (750 ul) were pre-incubated for 2 min at 37°C. Thereafter, haemoglobin substrate
solution (150 ul) was added in, and the reaction was allowed to proceed for 10 min at 37°C.
Reactions were terminated by the addition of TCA-stop solution (500 ul) and kept on ice.
The presence of TCA-soluble degradation products was determined at A280 using a Pharmacia
Ultraspec 2000 spectrophotometer. In control experiments, the enzyme sample was replaced
by dist. H2O in the reaction mix. The TCA-soluble supernatants of these reactions were used
as blanks for the corresponding reactions with active enzyme.
4.10.3 Results and discussion
3000 0.24





Figure 32. The effect of cysteine on trypsin hydrolysis of CBz-R-AMC and
haemoglobin.
Trypsin was incubated in assay buffer containing cysteine concentrations
ranging from 1-50 mM (Section 4.10.1). The activity of the enzyme
against CBz-R-AMC ( • ) and haemoglobin (•) was determined under
assay conditions described in Section 4.10.2. The data represents the mean
± s.d. (n=3).
Despite the mechanistic advantages of cysteine proteases, serine proteases are much more
prevalent in mammalian proteolytic systems. This suggests that the reason that cysteine
endoproleases were selected for use in the endosomal system might have more to do with
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their ability to be regulated by the rcdox environment, and/or their stability to highly reducing
conditions.
With increasing concentrations of cysteine, the activity of trypsin against CBz-R-AMC
progressively decreases (Fig. 32). Trypsin hydrolysis of haemoglobin shows increased
activity until 20 mM cysteine, but decreases thereafter. There is an increase in haemoglobin
proteolysis at 50 mM cysteine. The cause for this increase in not known. The activation of
proteolysis against haemoglobin at relatively low concentrations of cysteine is probably due
to the synergistic effects of hydrolysis and reduction on the haemoglobin substrate (Kooistra
at td., 1982). These effects are significant enough to offset the dcnaturation of the enzyme
observed with the activity of the enzyme against CBz-R-AMC. However, at higher thiol






































Figure 33. The effect of cysteine on papain hydrolysis of CBz-R-AMC and
haemoglobin at pH 7.0.
Papain was incubated in assay buffer containing cysteine concentrations
ranging from 1-50 mM (Section 4.10.1). The activity of the enzyme
against CBz-R-AMC ( • ) and haemoglobin (• ) was determined under
















Figure 34. The effect of cysteine on papain hydrolysis of CBz-R-AMC and
haemoglobin at pH 6.0.
Papain was incubated in assay buffer containing cysteine concentrations
ranging from 1-50 mM (Section 4.10.1). The activity of the enzyme
against CBz-R-AMC (• ) and haemoglobin (•) was determined under
assay conditions described in Section 4.10.2. The data represents the mean
± s.d. (n=3).
The neutral to alkaline pH optima of serine proteases would also preclude their use as
lysosomal endoproteases. At these higher pH's reductive denaturation of the enzymes would
be more favoured than at lower pH's. In contrast, and whilst cathepsin B does show a pH
dependent stability to reducing conditions, the enzyme appears to be stable to high
concentrations of thiol (Section 4.5). Serine proteases have evolved by divergent evolution
(Rawlings and Barrett, 1994) and the factors discussed above must therefore be tested over a
range of serine proteases before any definite conclusions are reached.
At pH 7.0, increases in cysteine concentration, until 25 mM, cause a decrease in papain
activity against CBz-R-AMC (Fig. 33). Thereafter, however, papain hydrolysis of the
fluoromctric substrate appears to be activated by cysteine, with a maximum at 30 mM
cysteine. In contrast, hydrolysis of haemoglobin appears to be stimulated by increasing
cysteine concentrations, with a maximum at 30 mM cysteine. At pH 6.0, hydrolysis of
haemoglobin and of CBz-R-AMC shows a similar response to changes in cysteine
concentration, with a local minimum at 20 mM cysteine and a maximum at 40 mM (Fig. 34).
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The hydrolysis of CBz-R-AMC proceeds at similar rates at pH 6.0 and pH 7.0. However,
against haemoglobin, papain is considerably more active at pH 7.0. The difference between
the hydrolysis of the fluorometric and haemoglobin substrates may reflect the effect of pH on
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Figure 35. The effect of cysteinexystine buffers on papain hydrolysis of
haemoglobin al pH 7.0.
Papain was incubated in assay buffers containing 1 mM cystine and with
cysteine at concentrations ranging from 1-50 mM (O). These reactions
were compared to the activity of the enzyme without cystine in the same
cysteine concentration range ( • ) . The buffers and assay conditions are
described in Sections 4.10.1 and 4.10.2. The data represents the mean ±
s.d. (n=3).
Papain hydrolysis of haemoglobin is stimulated by cystine at both pH 6.0 and pH 7.0 (Fig.
35-36). As described for cathepsin B hydrolysis of haemoglobin, this effect is a synergystic
effect between and the enzyme and the disulfide, and may be related to the oxidising effect of
cystine. At first glance these results appear to be contradictory to those obtained above where
increasing the reducing conditions stimulated proteolysis. However, in the envisioned redox
system cysteine and cystine would act in concert to stimulate proteolysis: cysteine to activate
cysieinc proteases and induce the loosening of substrate structure, and cystine to ensure that
aggregation of substrate due to hydrophobic interactions is inhibited.
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Figure 36. The effect of cysteineicystine buffers on papain hydrolysis of
haemoglobin at pH 6.0.
Papain was incubated in assay buffers containing 1 mM cystine and with
cysteine at concentrations ranging from 1-50 mM (O). These reactions
were compared to the activity of the enzyme without cystine in the same
cysteine concentration range ( • ) . The buffers and assay conditions are





At the outset of this study a model was proposed to explain the differences in functional states
between late endosomes and lysosomes. Late endosomes have been shown to be the main
site of substrate degradation in the endosomal pathway, despite having only a small fraction
of the lysosomal hydrolase pool. Lysosomes were proposed to be storage organelles that,
when necessary, injected their lumenal content into the late endosome (Tjelle et al., 1996). It
was hypothesised that the late endosome contained a more reducing environment that
activated cysteine proteases and stimulated proteolysis of substrate due to loosening of its
structure. Lysosomes, on the other hand, were envisioned to have relatively oxidising
environments that did not activate cysteine proteases. The vast majority of lysosomal
endopeptidases are cysteine proteases, and it is believed that they catalyse the rate-limiting
steps in substrate hydrolysis (Bohley and Seglen, 1992). Therefore, shutting them down
would effectively limit substrate proteolysis.
In order for the lysosome to maintain a relatively oxidising environment, the cysteine and
cystine transporters (Pisoni and Thoene, 1991) would have to be selectively distributed
between lysosomes and late endosomes, or else function differentially at the respective pH's
of these organelles. It is possible that the oxidising state within the lysosomes could be
maintained by the inactivation of the cysteine transporter. The cysteine transporter displays a
pH optimum of between 7.0 to 7.5. At acidic pH's (< pH 6.4) the transporter shows a
marked decrease in activity. Pisoni et al. (1990) suggested that this pH optimum for the
transporter may exist on both the lumenal and cytoplasmic sides of the membrane. The
oxidising environment of the lysosome may be generated by acidification of the lysosome,
which would inactivate the cysteine transporter. Also, the overall redox potential within the
system would inevitably become more oxidising at a lower pH. The increased oxidation state
within the lysosome may however, be incidental to the regulation of proteolysis within the
endosomal system (Section 4.6).
Apart from differences in their lumenal redox environment, this model proposed that the
injection of proteases into the late endosome from the lysosome represented a second
regulatory mechanism for substrate hydrolysis. Either lysosome-derived vesicles or the
lysosomes themselves would have to be made competent for fusion with the late endosome.
This process is expected to involve v-SNARE-t-SNARE interactions and the activation of the
appropriate Rab-protein machinery. Lysosomal endoproteases, inactivated by oxidation, may
become reductively activated by cysteine once they enter the reducing environment within the
late endosome. The physiological concentrations of cysteine and cystine, as well as their
relative concentrations within different parts of the endosomal system are not known. Part of
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the problem with quantifying these factors is that the environment is extremely dynamic.
Further, cysteine oxidises extremely rapidly (Mansoor et al, 1992) making physical
quantification technically difficult. In an attempt to quantify these redox parameters for the
proposed redox regulatory mechanism described above, the lysosomal cysteine protease,
cathepsin B, was isolated and its behaviour under various reducing conditions was tested.
The studies on the activation of isolated cathepsin B at different concentrations of cysteine,
showed the dependence of the reductive activation of the enzyme on pH. It was found that at
higher pH's, a lower concentration of cysteine was required to activate cathepsin B when
compared to lower pH's (Section 4.5). Thus (oxidised) cysteine proteases are more easily
activated at higher, rather than lower pH's. This activation must be balanced by the stability
of the enzymes, which appears to be greater at acidic, rather than neutral or alkaline pH's
(Dehrmann et al., 1996). Because conditions are more reducing at a higher than lower pH
for a given concentration of thiol (Segal, 1976), the cleavage of substrate disulfide bridges
might also be favoured at these higher pH's where cathepsin B is more easily activated.
The relationship between cathepsin B reductive activation and pH is consistent with the
inverse relationship between pH and standard reduction potential (Segal, 1976), suggesting
that the enzyme might have an optimal redox potential. In order to determine this potential,
cysteinexystine buffers were used to activate cathepsin B. The results for the activation of
the enzyme using the fluorometric substrate, CBz-R-R-AMC, did not reveal a specific
optimal potential. This may be because the system has too many variables that affect enzyme
activity. It is also possible that the enzyme has unique potentials geared to different pH
conditions. A new approach to tackle this question would be to try quantify the actual
physical or chemical changes (e.g. sulfinic acid to thiolate ion) associated with the enzyme's
activation. These results also demonstrated that enzyme may be activated at a purported
"threshold" potential, and that this potenial may be relatively oxidisng. This result cast doubt
on the proposed redox regulation of proteolysis. Once quantified this "threshold" potential
may provide a mechanism by which the enzyme is able to operate extracellularly in conditions
like cancer (Yan et al, 1998).
The work with cysteine:cystine redox buffers also opened a new branch of enquiry.
Unexpectedly, it was found that cystine-containing buffers promoted the hydrolysis of the
whole protein substrate, haemoglobin, by cathepsin B, cathepsin D (an aspartic protease) and
papain. This effect was not due to the activation of the actual catalytic mechanisms of the
enzymes involved, since it affected both the cysteine proteases and the aspartic protease.
Further, this activation effect was not detected using fluorometric substrates, and ligand-
binding studies indicated that cystine was not binding to a physical site on cathepsin B.
Thus, this effect was most probably directed at the haemoglobin substrate and is possibly due
to the ability of cystine to prevent aggregation of protein (Raman etai, 1996).
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This is the first report to suggest that cystine, as opposed to cysteine, might play an active
role in endosomal proteolysis and that it might be more than a by-product of hydrolysis. This
finding is supported by the finding that cystine does get imported into the "lysosome" (Pisoni
and Thoene, 1991). It is envisioned that cysteine and cystine set up a redox buffer system
that activates cysteine proteases and stimulates proteolysis through the reduction of the
disulfide linkages in a substrate. This system must however ensure that substrate is not lost
through hydrophobic aggregation, a process that is likely to happen as a protein gets broken
down from its tertiary structure to its component amino acids. Cuervo and Dice (1998) have
shown that the chaperonin, hsc 73, is selectively imported into the endosomal system by its
interaction with the integral membrane protein LAMP-2. Whether hsc 73 acts in concert with
the cysteinexystine redox buffer, to prevent inappropriate aggregation in the complex
endosomal milieu, remains to be seen.
The results presented here do not actually demonstrate the presence of this system in vivo.
However, it must be remembered that the existence of such a system has not been described
before, possibly because the concept of promoting protein structure within the degradative
endosomal environment appeai-s paradoxical to the functions of the system. The possible
loss of protein through aggregation, and the rapidity at which it could occur (Goldberg et al.,
1991), has perhaps not been properly appreciated. Secondly, most protocols describing the
action of lysosomal cysteine proteases against whole protein substrates are often carried out
over several hours and without protection against oxygen (see for example Blair et a I., 1993
and Buck et al., 1992). The assays described in this dissertation were all carried out over 10
minutes, which is more in keeping with the half-life of a substrate within the endosomal
system (Bohley and Seglen, 1992). With buffers not appropriately deoxygenated, the redox
conditions within those experiments carried out over several hours without protection against
oxygenation, would be expected to change during the assay. Cysteine oxidises extremely
rapidly to form cystine (Mansoor et al., 1992), so the results obtained without protection
against oxidation may reflect a cystine-mediated stimulation of proteolysis. This would affect
the rate of substrate hydrolysis (Section 4.5), and perhaps the stability of the enzymes
themselves (Dehrmann etal, 1996).
As this study progressed, the effects of pH on the reductive activation of cathepsin B opened
another avenue of enquiry. The differences in reduction potential between the late endosome
and Jysosome could probably not, by themselves, account for the regulation of hydrolysis.
Firstly, the results obtained in Section 4.6 demonstrate that the cathepsin B ca operate under
relatively oxidising conditions. Secondly, it has been shown by Meinesz (1996) that the
activity of lysosomal acid a-glucosidase is not regulated by changing thiol conditions. An
expectation of any regulatory mechanism would be that it would include all hydrolases within
the system. Finally, these proposed differences in the redox potential cannot account for the
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different morphologies of the two organelles. Late endosomes appear to be complex,
relatively large organelles, whilst lysosomes appear to be small highly dense organelles
(Griffiths, 1996).
It was suspected that another regulatory mechanism may exist. Clues to the operation of this
possible mechanism came from the work of Kostoulas et al. (1997). These authors found
that elastase and other enzymes found within the azurophil granules of human neutrophils
bound to sulfonated glycosaminoglycans by electrostatic interactions at low pH. It was
proposed that this was a storage mechanism for these enzymes. A feature of secretory
granules is that they contain condensed cores of aggregated proteins, a morphology similar to
that described for lysosomes (Griffiths, 1996). The aggregation process begins in the TGN
and is complete once the granules have matured. Using bovine pituitary gland cells, it was
demonstrated that the granule content proteins and the lumenal domains of granule membrane
proteins could aggregate at low pH (< pH 5.5). A similar result was obtained for bovine
adrenal glands, although aggregation depended on the presence of Ca2+. Quite remarkably,
proteins that were destined for constitutive secretion did not aggregate with the granule
content and lumenal membrane proteins, and this property may serve as a segregation
mechanism for those proteins that need to be stored and those that are constitutively secreted
(Colomzx etal, 1996).
The pH-dependent (pH 4.8) aggregation of lysosomal enzymes has been described in
Chinese hamster ovary (CHO) cells (Buckmaster et al., 1988). This aggregation was
disrupted by NaCl, suggesting that an electrostatic mechanism was responsible for
aggregation. Horseradish peroxidase (HRP) that had been chased into the CHO cells failed
to aggregate with the lysosomal enzymes. As was the case for the secretory granules
described above, aggregation was specific. Jadot et al. (1997) were also able to show that
aggregation of rat liver lysosomal enzymes occurs at low pH. This aggregation process,
which occurred between pH 4.5-5.0, was mediated by the integral membrane protein
LAMP-2. Under these low pH conditions, lysosomal enzymes bind by electrostatic
interactions to the LAMP-2 proteins, immobilising them in a matrix. Once again this process
was specific for the eleven lysosomal hydrolases assayed during the experiment. A cytosolic
extract and bovine serum albumin (BSA), failed to aggregate with LAMP-2 under the
conditions tested. Unlike the aggregation observed in CHO cells (Buckmaster et al., 1988),
detergents affected aggregation of the rat liver lysosomal enzymes, suggesting that membrane
association with LAMP-2 was vital for aggregation.
A pH-dependent aggregation mechanism could operate to withdraw lysosomal hydrolases out
of the late endosome, or it could just be a feature of the lysosome itself. An advantage of this
complexation mechanism, as opposed to a redox-dependent storage mechanism, is that it
appears to involve several different types of lysosomal hydrolases from Upases to proteases
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(Jadot et al, 1997). Further, as described by Griffiths (1996), under the electron microscope
lysosomes appear to be small, highly dense organelles, a morphology that could be explained
by aggregation of the lysosomal hydrolases within their lumens.
The concept of lysosomal enzymes aggregating by electrostatic interactions is a fairly old one
(see for example Henning et al, 1973). However, the acceptance of this mechanism as a
means of regulating and storing lysosomal hydrolases has been limited because erroneously
low pH optima were assigned to the hydrolases (Dehrmann et al. 1995), and the assumption
that lysosomes (with their corresponding low pH) represented the organelle where the bulk of
substrate hydrolysis occurs. The hypothesis described above does not exclude the possibility
that the late endosome may fluctuate between alkaline and acidic pH's, allowing for the
activation of many different hydrolases with their individual pH optima (Butor et al, 1995).
The lysosome with its low pH may complex the lysosomal hydrolases, effectively storing
them in a matrix.
The original model for regulating proteolysis along the endosomal pathway described at the
start of this dissertation (Chapter 1), may in fact not exist. Our current model now
encompasses two systems responsible for the regulation of proteolysis. The first system
regulates the injection of proteases into the late endosome, and presumably their exit from this
organelle. Once the hydolases have been correctly sorted, a lysosomal storage mechanism
may complex the lysosomal hydrolases to membrane glycoproteins at low pH, storing them
in a matrix.
The ultimate result of the present study has thus been a model which explains the
observations of Tjelle et al. (1996), that late endosomes are the main site of substrate
degradation, whilst lysosomes are storage organelles. The function of this model in vivo
needs to be proved and it also raises several questions, viz.:
• How does the system regulate the injection of hydrolases into the late endosome? In the
discussion above it was hypothesised that the regulatory mechanism was based on the
lysosome or lysosomal vesicles acquiring factors that made them competent for fusion
with the late endosome. This implies that there is a sensor(s) that detect the presence of
substrate within the late endosome. It is also possible that the fusion of the lysosome to
the late endosome may be a cyclic event regulated by a rab-GTP/GDP timer. This
question is further complicated by the finding by Claus et al. (1998) that the lysosomal
population is highly heterogenous, suggesting the possibility of different regulatory
mechanisms.
• Is there any evidence that the lumenal endosomal environment is involved in preventing
aggregation? The results of the present study suggest that cystine stimulates proteolysis,
but the mechanism by which this occurs still needs to be proved. If this is in fact due to
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the ability of cystine to promote substrate conformation, then this could occasion a
paradigm shift in the way that substrate hydrolysis along the endosomal pathway is
viewed. Substrate hydrolysis may be far more regulated than previously imagined.
Apart from their broad substrate specificity, pH stability, and their efficient catalytic
mechanisms, lysosomal cysteine proteases may have been selected for the endosomal
system because of their stability in this redox system.
• Is there a correlation between the pH and density oflysosomes? The evidence for the use
of acid-dependent aggregation as a storage mechanism in secretory granules and
neutrophil granules has been well documented. If the aggregation dependent storage
mechanism described above actually exists in the endosomal system then there should be
a correlation between the morphology and density of lysosomes and their lumenal pH. A
further intriguing question is how this aggregation mechanism may be regulated.
These and related questions suggest many possible avenues for future research. Basic
research of this nature will undoubtedly provide further insights, which may have significant,
though unforeseeable, applications in many areas of applied medicine.
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